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Abstract	  
The	  modular	  design	  of	  the	  multi-­‐subunit	  SCF	  ubiquitin	  ligases	  allows	  for	  recognition	  of	  a	  diverse	  set	  of	  target	  proteins.	  However,	  the	  speed	  and	  complexity	  of	  the	  SCF	  ubiquitylation	  reaction	  have	  precluded	  direct	  experimental	  tests	  to	  understand	  how	  SCF	  complex	  formation	  is	  regulated	  and	  the	  pathway	  by	  which	  ubiquitin	  chains	  are	  generated.	  Herein	  we	  introduce	  new	  theoretical	  and	  experimental	  methodologies	  to	  address	  both	  limitations.	  First,	  a	  quantitative	  framework	  based	  on	  product	  distribution	  predicts	  that	  the	  really	  interesting	  new	  gene	  (RING)	  E3s	  SCFCdc4	  and	  SCFβ-­‐TrCP	  work	  with	  the	  E2	  Cdc34	  to	  build	  polyubiquitin	  chains	  on	  substrates	  by	  sequential	  transfers	  of	  single	  ubiquitins.	  Measurements	  with	  millisecond	  time	  resolution	  directly	  demonstrate	  that	  substrate	  polyubiquitylation	  proceeds	  sequentially.	  Second,	  we	  present	  a	  novel	  FRET	  assay	  that	  enables	  real-­‐time	  measurements	  of	  binding	  dynamics	  of	  the	  SCFFbxw7	  complex.	  We	  find	  that	  the	  Cul1-­‐associated	  protein	  CAND1	  is	  able	  to	  actively	  remove	  Fbxw7/Skp1	  from	  Cul1/Rbx1	  by	  changing	  the	  dissociation	  rate	  of	  the	  complex	  a	  million-­‐fold,	  yet	  CAND1	  does	  not	  affect	  the	  assembly	  rate	  of	  SCFFbxw7.	  This	  activity	  is	  abolished	  when	  Cul1	  is	  neddylated.	  Experiments	  show	  that	  CAND1	  accelerates	  the	  rate	  at	  which	  multiple	  SCF	  complexes	  can	  form.	  Thus,	  CAND1	  appears	  to	  function	  as	  an	  exchange	  factor.	  Lastly,	  several	  measurements	  reveal	  an	  extra	  step	  in	  the	  ubiquitylation	  pathway	  for	  yeast	  SCF	  that	  implies	  a	  substrate	  induced	  conformational	  change	  exists	  for	  Fbox	  proteins.	  These	  results	  present	  an	  unprecedented	  glimpse	  into	  the	  mechanism	  of	  RING	  ubiquitin	  ligases	  and	  their	  regulation	  by	  CAND1.	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In	  the	  past	  30	  years,	  the	  degradation	  of	  proteins	  through	  the	  ubiquitin	  proteasome	  system	  (UPS)	  has	  emerged	  as	  an	  essential	  process	  that	  governs	  a	  wide	  range	  of	  biological	  processes.	  As	  such,	  mutations	  in	  many	  of	  the	  basic	  UPS	  components	  are	  now	  understood	  to	  serve	  as	  the	  underlying	  molecular	  cause	  of	  several	  diseases	  and	  disorders.	  Understanding	  the	  fundamental	  mechanisms	  of	  how	  the	  UPS	  works	  gives	  promise	  for	  the	  development	  of	  future	  treatments.	  
	  
Discovery	  of	  Ubiquitin	  	  Results	  from	  early	  metabolic	  studies	  in	  rats	  revealed	  that	  protein	  turnover	  was	  extensive	  and	  rapid	  (Schoenheimer	  et	  al.,	  1939).	  Protein	  degradation	  was	  initially	  thought	  to	  occur	  exclusively	  in	  the	  lysosome,	  an	  intracellular	  compartment	  with	  destructively	  low	  pH	  that	  at	  the	  time	  was	  known	  to	  degrade	  proteins	  after	  endocytosis.	  However,	  several	  studies	  indicated	  that	  ATP	  was	  required	  for	  the	  specific	  degradation	  of	  certain	  types	  of	  abnormal	  proteins.	  This	  indicated,	  although	  it	  did	  not	  prove,	  that	  mechanisms	  existed	  outside	  the	  context	  of	  the	  lysosome	  that	  were	  responsible	  for	  protein	  catabolism.	  The	  beginnings	  of	  the	  UPS	  field	  can	  be	  traced	  back	  to	  the	  seminal	  work	  of	  Alfred	  Goldberg	  at	  Harvard	  Medical	  School.	  Goldberg	  and	  colleagues	  established	  a	  cell-­‐free	  system	  in	  rabbit	  reticulocyte	  lysate	  that	  recapitulated	  the	  ATP-­‐dependent	  degradation	  of	  hemoglobin	  upon	  mis-­‐incorporation	  of	  the	  valine	  analog	  2-­‐amino-­‐3-­‐chlorobutyric	  acid	  (ClAbu)	  (Etlinger	  and	  Goldberg,	  1977).	  Using	  this	  assay,	  the	  lab	  of	  Avram	  Hershko	  set	  out	  to	  find	  the	  enzymes	  that	  were	  responsible	  for	  this	  activity	  through	  biochemical	  fractionation	  of	  the	  lysate.	  The	  group	  discovered	  a	  small,	  heat-­‐stable	  protein	  that	  was	  required	  for	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activity	  (Ciechanover	  et	  al.,	  1978).	  The	  group	  of	  Art	  Haas	  quickly	  discovered	  that	  this	  protein	  was	  in	  fact	  ubiquitin,	  an	  abundant	  eukaryotic	  protein	  with	  unknown	  function	  that	  had	  been	  shown	  to	  become	  covalently	  linked	  to	  histone	  2A	  (Wilkinson	  et	  al.,	  1980;	  Goldstein	  et	  al.,	  1975;	  Goldknopf	  and	  Busch,	  1977).	  In	  a	  now	  famous	  paper,	  Hershko	  and	  Irwin	  Rose	  observed	  radiolabeled	  ubiquitin	  attachment	  to	  lysozyme	  and	  proposed	  that	  ubiquitin	  attachment	  to	  proteins	  served	  as	  an	  intermediate	  to	  the	  delivery	  of	  proteins	  to	  some	  unknown	  protease	  (Hershko	  et	  al.,	  1980).	  This	  served	  as	  the	  reason	  for	  the	  ATP	  dependence	  on	  protein	  degradation	  activity	  seen	  in	  the	  lysate.	  	  
	  
The	  Ubiqutin	  Enzymes	  In	  general,	  a	  sequential	  cascade	  of	  three	  enzymes	  carries	  out	  the	  transfer	  of	  mono-­‐ubiquitin	  to	  target	  proteins	  and	  the	  synthesis	  of	  polyubiquitin	  chains:	  a	  ubiquitin	  activating	  enzyme	  (E1),	  a	  ubiquitin	  conjugating	  enzyme	  (E2),	  and	  a	  ubiquitin	  ligase	  (E3)	  (Figure	  1.1)	  (Dye	  et	  al.,	  2007).	  The	  E1	  enzyme	  uses	  ATP	  to	  catalyze	  the	  formation	  of	  an	  adenylate	  conjugate	  at	  the	  C-­‐terminus	  of	  ubiquitin	  (Hershko	  et	  al.,	  1981).	  This	  high-­‐energy	  intermediate	  is	  hydrolyzed	  to	  directly	  attach	  the	  E1	  to	  ubiquitin	  through	  a	  thiolester	  linkage	  between	  an	  active	  site	  cysteine	  on	  the	  E1	  and	  the	  C-­‐terminus	  of	  ubiquitin	  (Haas	  et	  al.,	  1982).	  Almost	  all	  eukaryotic	  organisms	  have	  a	  single	  ubiquitin	  E1,	  with	  the	  exception	  of	  humans,	  which	  have	  two	  (Jin	  et	  al.,	  2007).	  Most	  organisms	  have	  around	  ten	  E2s.	  E2s	  interact	  directly	  with	  the	  E1	  and	  the	  ubiquitin	  is	  transferred	  from	  the	  catalytic	  cysteine	  of	  the	  E1	  to	  the	  catalytic	  cysteine	  of	  the	  E2.	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The	  UPS	  highlights	  several	  modern	  aspects	  of	  the	  understanding	  of	  proteins	  in	  biology.	  First,	  post-­‐translational	  modifications	  of	  proteins	  serve	  to	  expand	  and	  regulate	  the	  function	  of	  a	  wide	  array	  of	  cellular	  processes.	  Second,	  degradation	  of	  proteins	  is	  a	  mechanism	  of	  control	  critical	  for	  proper	  cellular	  signaling	  and	  function.	  This	  is	  pronounced	  by	  the	  vast	  array	  of	  diseases	  that	  are	  currently	  linked	  with	  the	  ubiquitin	  proteasome	  system.	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Chapter	  2:	  
Detection	  of	  Sequential	  Polyubiquitylation	  on	  a	  Millisecond	  Timescale*	  
	  	  	  	  	  	  	  	  
*This	  chapter,	  first	  published	  in	  Nature	  in	  2009,	  was	  written	  by	  Nathan	  W.	  Pierce,	  Gary	  Kleiger,	  Shu-­‐ou	  Shan,	  and	  Raymond	  J.	  Deshaies.	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Abstract	  
The	  pathway	  by	  which	  ubiquitin	  chains	  are	  generated	  on	  substrate	  via	  a	  cascade	  of	  enzymes	  consisting	  of	  an	  E1,	  E2,	  and	  E3	  remains	  unclear.	  Multiple	  distinct	  models	  involving	  chain	  assembly	  on	  E2	  or	  substrate	  have	  been	  proposed.	  However,	  the	  speed	  and	  complexity	  of	  the	  reaction	  have	  precluded	  direct	  experimental	  tests	  to	  distinguish	  between	  potential	  pathways.	  Here	  we	  introduce	  new	  theoretical	  and	  experimental	  methodologies	  to	  address	  both	  limitations.	  A	  quantitative	  framework	  based	  on	  product	  distribution	  predicts	  that	  the	  really	  interesting	  new	  gene	  (RING)	  E3s	  SCFCdc4	  and	  SCFβ-­‐TrCP	  work	  with	  the	  E2	  Cdc34	  to	  build	  polyubiquitin	  chains	  on	  substrates	  by	  sequential	  transfers	  of	  single	  ubiquitins.	  Measurements	  with	  millisecond	  time	  resolution	  directly	  demonstrate	  that	  substrate	  polyubiquitylation	  proceeds	  sequentially.	  Our	  results	  present	  an	  unprecedented	  glimpse	  into	  the	  mechanism	  of	  RING	  ubiquitin	  ligases	  and	  illuminate	  the	  quantitative	  parameters	  that	  underlie	  the	  rate	  and	  pattern	  of	  ubiquitin	  chain	  assembly.	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Introduction	  
Attachment	  of	  a	  polyubiquitin	  chain	  with	  at	  least	  four	  ubiquitins	  linked	  together	  through	  their	  lysine	  48	  residue	  (Lys48)	  targets	  proteins	  to	  the	  proteasome	  for	  degradation	  (Thrower	  et	  al.,	  2000).	  A	  cascade	  of	  three	  enzymes	  carries	  out	  the	  synthesis	  of	  polyubiquitin	  chains:	  a	  ubiquitin	  activating	  enzyme	  (E1),	  a	  ubiquitin	  conjugating	  enzyme	  (E2),	  and	  a	  ubiquitin	  ligase	  (E3)	  (Dye	  et	  al.,	  2007).	  RING	  (really	  interesting	  new	  gene)	  E3s	  catalyze	  the	  direct	  transfer	  of	  ubiquitin	  from	  an	  E2	  to	  a	  lysine	  on	  a	  target	  protein	  (Petroski	  and	  Deshaies,	  2005a).	  SCFCdc4	  is	  the	  founding	  member	  of	  the	  largest	  family	  of	  E3s—the	  cullin-­‐RING	  ubiquitin	  ligases	  (CRLs)	  that	  may	  comprise	  the	  majority	  of	  all	  human	  ubiquitin	  ligases	  (Petroski	  and	  Deshaies,	  2005a).	  	  Thus,	  unraveling	  the	  mechanism	  of	  SCF	  will	  have	  broad	  functional	  ramifications	  for	  the	  preponderance	  of	  human	  E3s.	  	  Different	  pathways	  for	  ubiquitin	  chain	  assembly	  by	  RING	  E3s	  have	  been	  envisioned	  based	  on	  indirect	  evidence.	  On	  the	  one	  hand,	  Cdc34-­‐SCF	  ubiquitylates	  substrates	  bearing	  a	  single	  ubiquitin	  significantly	  faster	  than	  non-­‐ubiquitylated	  substrates	  (Saha	  and	  Deshaies,	  2008;	  Petroski	  and	  Deshaies,	  2005b),	  suggesting	  that	  it	  processively	  builds	  polyubiquitin	  chains	  on	  substrates	  with	  an	  initial	  slow	  transfer	  of	  ubiquitin	  followed	  by	  rapid	  elongation	  into	  a	  Lys48-­‐linked	  polyubiquitin	  chain.	  On	  the	  other	  hand,	  the	  E2	  Ube2g2,	  a	  close	  relative	  of	  Cdc34,	  collaborates	  with	  the	  E3	  gp78	  to	  build	  a	  polyubiquitin	  chain	  on	  its	  active	  site	  cysteine	  that	  can	  be	  transferred	  en	  bloc	  to	  substrate	  (Ravid	  and	  Hochstrasser,	  2007;	  Li	  et	  al.,	  2007).	  Various	  permutations	  of	  the	  en	  bloc	  mechanism	  have	  been	  entertained,	  in	  which	  the	  chain	  is	  built	  either	  from	  proximal	  to	  distal	  end	  or	  vice	  versa	  (Hochstrasser,	  2006;	  Li	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et	  al.,	  2009;	  Deshaies	  and	  Joazeiro,	  2009).	  Due	  to	  the	  rapid	  speed	  of	  ubiquitin	  chain	  synthesis,	  intermediates	  that	  would	  reveal	  the	  underlying	  pathway	  cannot	  be	  kinetically	  resolved.	  Thus,	  it	  has	  not	  been	  possible	  to	  establish	  definitively	  the	  pathway	  of	  chain	  assembly	  for	  any	  RING	  E3.	  Here	  we	  introduce	  new	  theoretical	  and	  experimental	  methodologies	  to	  address	  both	  limitations.	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Results	  
Quantitative	  analysis	  of	  product	  distribution	  Processivity	  emerges	  from	  the	  relationships	  between	  reaction	  and	  dissociation	  rates	  for	  different	  product	  intermediates	  (Fersht,	  1999).	  To	  quantify	  the	  processivity	  of	  SCF,	  we	  established	  an	  assay	  capable	  of	  simultaneously	  monitoring	  the	  concentrations	  of	  substrate	  and	  its	  different	  ubiquitylated	  product	  intermediates.	  Our	  assay	  consisted	  of	  an	  engineered	  phosphopeptide	  substrate	  derived	  from	  human	  Cyclin	  E1	  (CycE)	  and	  purified	  Saccharomyces	  cerevisiae	  Cdc34-­‐SCFCdc4	  (Saha	  and	  Deshaies,	  2008;	  Petroski	  and	  Deshaies,	  2005b;	  Nash	  et	  al.,	  2001).	  CycE	  was	  selected	  because	  it	  is	  a	  defined,	  chemically	  homogeneous	  substrate	  that	  binds	  with	  high	  affinity	  to	  the	  substrate-­‐binding	  pocket	  of	  SCFCdc4	  (Nash	  et	  al.,	  2001;	  Orlicky	  et	  al.,	  2003).	  Moreover,	  intact	  Cyclin	  E	  is	  a	  substrate	  of	  SCFCdc4	  in	  vivo	  (Strohmaier	  et	  al.,	  2001)	  and	  the	  degron	  from	  CycE	  can	  support	  turnover	  in	  vivo	  of	  an	  engineered	  substrate,	  Sic1,	  from	  which	  the	  endogenous	  degrons	  have	  been	  eliminated	  (Nash	  et	  al.,	  2001).	  To	  examine	  the	  simplest	  system	  that	  recapitulated	  the	  processive	  behavior	  of	  Cdc34-­‐SCFCdc4,	  we	  focused	  on	  single	  turnover	  reaction	  conditions	  containing	  an	  excess	  of	  SCFCdc4	  over	  radiolabeled	  CycE.	  We	  initiated	  reactions	  by	  combining	  two	  pre-­‐incubated	  mixtures:	  the	  ‘charged	  E2’	  mixture	  containing	  ubiquitin,	  E1,	  ATP,	  and	  Cdc34	  was	  pre-­‐incubated	  for	  two	  minutes	  to	  ensure	  the	  formation	  of	  saturating	  concentrations	  of	  Cdc34~ubiquitin	  thioesters	  (E2~Ub),	  and	  the	  ‘substrate-­‐ligase’	  mixture	  containing	  SCF	  and	  radiolabeled	  substrate	  was	  pre-­‐incubated	  to	  ensure	  the	  formation	  of	  an	  enzyme-­‐substrate	  complex.	  To	  maximize	  resolution	  of	  ubiquitin	  conjugates,	  the	  reaction	  products	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were	  fractionated	  on	  long	  SDS-­‐polyacrylamide	  gels.	  Consistent	  with	  previous	  assays	  performed	  with	  Sic1	  (Petroski	  and	  Deshaies,	  2005b),	  conjugation	  of	  the	  Nedd8	  homologue	  Rub1	  to	  the	  Cdc53	  subunit	  of	  budding	  yeast	  SCFCdc4	  did	  not	  alter	  the	  ubiquitylation	  kinetics	  of	  CycE	  (Supplementary	  Figure	  A.1),	  and	  thus	  all	  subsequent	  SCFCdc4	  assays	  were	  performed	  with	  unmodified	  E3.	  	  Under	  these	  reaction	  conditions,	  CycE	  was	  extensively	  polyubiquitylated	  by	  Cdc34-­‐SCFCdc4	  within	  30	  seconds	  (reaction	  1,	  Figure	  2.1a),	  and	  products	  containing	  ≥	  6	  ubiquitins	  were	  visible	  within	  10	  seconds	  (Supplementary	  Figure	  A.1).	  Thus,	  with	  the	  time	  resolution	  offered	  by	  manual	  mixing	  it	  was	  not	  apparent	  whether	  ubiquitin	  conjugates	  were	  formed	  by	  multiple	  sequential	  transfers	  of	  monoubiquitin	  or	  by	  en-­‐bloc	  transfer	  of	  pre-­‐formed	  chains.	  However,	  we	  reasoned	  that	  quantitative	  analysis	  of	  the	  length	  distribution	  of	  polyubiquitin	  chains	  attached	  to	  CycE	  during	  a	  single	  encounter	  with	  SCF	  might	  provide	  clues	  to	  the	  pathway	  of	  chain	  assembly.	  To	  determine	  the	  length	  distribution	  we	  carried	  out	  reactions	  with	  1,000-­‐fold	  excess	  chase	  of	  the	  unlabeled	  substrate	  peptide	  added	  to	  the	  ‘charged	  E2’	  mixture	  (reaction	  2,	  Figure	  2.1a).	  Under	  these	  conditions,	  radiolabeled	  substrate	  pre-­‐bound	  to	  SCF	  was	  rapidly	  ubiquitylated,	  but	  upon	  dissociation	  further	  ubiquitylation	  occurred	  at	  a	  significantly	  reduced	  rate	  due	  to	  competition	  from	  the	  chase	  peptide.	  To	  evaluate	  the	  effectiveness	  of	  the	  chase,	  we	  carried	  out	  a	  parallel	  reaction	  in	  which	  the	  chase	  peptide	  was	  added	  to	  the	  ‘substrate-­‐ligase’	  mixture	  prior	  to	  initiation	  (reaction	  3,	  Figure	  2.1a).	  The	  distribution	  of	  products	  in	  reaction	  3	  was	  subtracted	  from	  the	  distribution	  of	  products	  in	  reaction	  2	  at	  each	  time	  point	  (Supplementary	  Figure	  A.2)	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Figure	  2.1	  |	  Final	  product	  distribution	  for	  SCFCdc4	  and	  CycE.	  a,	  In	  reaction	  1,	  pre-­‐incubated	  32P-­‐labeled	  CycE	  and	  SCFCdc4	  were	  added	  to	  the	  charged	  E2	  mix.	  	  In	  reactions	  2	  and	  3,	  excess	  unlabeled	  CycE	  was	  pre-­‐incubated	  with	  charged	  E2	  mix	  and	  labeled	  CycE,	  respectively.	  b,	  The	  single	  encounter	  polyubiquitin	  chain	  length	  distribution,	  λCycE.	  Error	  bars:	  +/-­‐	  SD,	  n=3.	  c,	  If	  η(1)=100%,	  then	  φ=λ.	  d,	  If	  φ(1)=100%,	  then	  η=λ.	  e,	  Deconvolution	  of	  λCycE	  and	  exponentially	  distributed	  η.	  f,	  Deconvolution	  of	  λCycE	  and	  normal	  distributed	  φ.	  g,	  Mass	  spectrometry	  of	  Cdc34	  thioesterified	  for	  2’	  with	  indicated	  components.	  h,	  Simulated	  kinetics	  η(1)=100%.	  i,	  Simulated	  kinetics	  φ(1)=100%.	  	  to	  yield	  the	  average	  distribution	  for	  substrate,	  λ	  (Figure	  2.1b).	  Three	  main	  points	  were	  highlighted	  by	  these	  experiments.	  First,	  it	  is	  evident	  from	  reaction	  2	  that	  the	  single	  encounter	  reaction	  was	  complete	  within	  30	  seconds.	  Second,	  72%	  of	  CycE	  encounters	  with	  SCFCdc4	  resulted	  in	  no	  ubiquitin	  modification	  (Figure	  2.1a	  and	  Supplementary	  Figure	  A.2).	  Third,	  of	  those	  substrates	  that	  were	  modified,	  68%	  of	  CycE	  acquired	  a	  polyubiquitin	  chain	  with	  4	  or	  more	  ubiquitins	  (Figure	  2.1b).	  We	  next	  sought	  to	  develop	  a	  quantitative	  framework	  to	  address	  whether	  the	  experimentally	  determined	  product	  distribution	  λCycE	  (Figure	  2.1b)	  places	  constraints	  on	  the	  potential	  pathways	  of	  ubiquitin	  chain	  assembly.	  We	  considered	  three	  hypothetical	  situations.	  First,	  we	  imagined	  that	  only	  monoubiquitin	  was	  attached	  in	  each	  transfer	  event	  (Figure	  2.1c,	  ‘sequential’).	  Binning	  all	  of	  the	  transfer	  events	  per	  substrate	  gave	  the	  transfer	  distribution	  φ,	  which	  in	  this	  case	  would	  equal	  λ.	  Second,	  we	  imagined	  the	  other	  extreme	  in	  which	  only	  one	  transfer	  event	  occurs	  per	  substrate	  (Figure	  2.1d,	  ‘en-­‐bloc’).	  In	  this	  case,	  λ	  would	  be	  equal	  to	  the	  distribution	  of	  pre-­‐assembled	  polyubiquitin	  chains	  thioesterified	  to	  E2,	  which	  we	  named	  η.	  Third,	  we	  considered	  permutations	  that	  combined	  sequential	  and	  en	  bloc	  
	   14	  
transfers.	  For	  example,	  there	  are	  eight	  possible	  ways	  of	  making	  substrate	  modified	  with	  four	  ubiquitins	  (Sn,	  where	  n=4),	  including	  two	  transfers	  of	  diubiquitin	  or	  transfer	  of	  monoubiquitin	  followed	  by	  transfer	  of	  triubiquitin,	  etc.	  From	  this	  analysis,	  a	  key	  point	  emerged:	  regardless	  of	  the	  type	  of	  distribution	  we	  started	  with,	  the	  family	  of	  η	  and	  φ	  distributions	  compatible	  with	  λCycE	  (see	  Supplementary	  Methods)	  was	  restricted	  to	  extreme	  cases	  where	  either	  η	  or	  φ	  was	  nearly	  equal	  to	  λCycE	  (Figure	  2.1e,	  f	  and	  Supplementary	  Figure	  A.3-­‐7).	  Therefore,	  the	  vast	  majority	  of	  substrates	  either	  underwent	  one	  transfer	  per	  binding	  event	  or	  received	  a	  single	  ubiquitin	  per	  transfer	  event.	  Thus,	  accurately	  measuring	  product	  distribution	  constrained	  the	  number	  of	  possible	  pathways	  that	  could	  give	  rise	  to	  the	  reaction	  products	  we	  observed.	  As	  a	  first	  test	  of	  whether	  ubiquitins	  were	  transferred	  all	  at	  once	  or	  sequentially,	  we	  measured	  the	  distribution	  of	  polyubiquitin	  chain	  lengths	  present	  on	  the	  active	  site	  of	  Cdc34	  in	  the	  presence	  or	  absence	  of	  SCFCdc4	  by	  intact	  mass	  spectrometry.	  Cdc34	  subjected	  to	  our	  standard	  ‘charged	  E2’	  pre-­‐incubation	  was	  completely	  converted	  to	  thioesters	  carrying	  a	  single	  ubiquitin	  (Cdc34~Ub;	  Fig.	  1g	  and	  Supplementary	  Figure	  A.10).	  In	  the	  presence	  of	  SCFCdc4,	  89%	  of	  Cdc34	  was	  detected	  as	  Cdc34~Ub	  and	  11%	  was	  unmodified;	  no	  Cdc34	  species	  with	  more	  than	  one	  ubiquitin	  attached	  were	  detected.	  A	  control	  experiment	  run	  with	  diubiquitin	  confirmed	  that	  our	  assay	  was	  able	  to	  detect	  diubiquitin	  chains	  thioesterified	  to	  the	  active	  site	  of	  Cdc34	  (Cdc34~Ub2;	  Supplementary	  Figure	  A.11),	  but	  charging	  of	  Cdc34	  with	  diubiquitin	  occurs	  with	  poor	  efficiency	  (~	  20%).	  Thus,	  our	  analysis	  of	  the	  product	  distribution	  λ	  coupled	  with	  measurement	  of	  the	  ubiquitin	  population	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thioesterified	  to	  Cdc34	  under	  our	  reaction	  conditions	  (an	  estimate	  of	  η)	  strongly	  predicts	  that	  Cdc34–SCFCdc4	  assembles	  ubiquitin	  chains	  on	  substrate	  primarily	  by	  sequential	  transfers	  of	  single	  ubiquitin	  molecules.	  	  
Millisecond	  kinetics	  of	  SCF	  As	  a	  second,	  more	  definitive	  test	  of	  the	  hypothesis	  stated	  above,	  we	  sought	  to	  measure	  directly	  how	  the	  product	  distribution	  (Figure	  2.1b)	  developed	  as	  a	  function	  of	  time.	  During	  a	  single	  encounter	  between	  a	  RING	  ubiquitin	  ligase	  and	  substrate,	  each	  intermediate	  should	  either	  undergo	  a	  transfer	  event	  or	  dissociate.	  If	  monoubiquitin	  is	  composed	  100%	  of	  η	  as	  in	  Figure	  2.1c,	  the	  products	  of	  the	  reaction	  should	  appear	  sequentially	  in	  time	  starting	  with	  S1	  and	  followed	  by	  S2,	  then	  S3,	  etc.	  Thus,	  the	  appearance	  of	  each	  sequential	  product	  should	  be	  delayed	  by	  a	  ‘lag’	  phase	  (Figure	  2.1h).	  In	  contrast,	  if	  a	  single	  transfer	  composed	  100%	  of	  φ	  as	  in	  Fig.	  1d,	  then	  the	  pattern	  of	  ubiquitin	  chains	  attached	  to	  substrate	  at	  the	  earliest	  time-­‐points	  should	  reveal	  the	  distribution	  of	  pre-­‐assembled	  chains	  thioesterified	  to	  Cdc34	  (Fig.	  1i).	  Thus,	  products	  of	  increasing	  mass	  should	  accumulate	  sequentially	  if	  chain	  synthesis	  is	  sequential,	  but	  should	  accumulate	  contemporaneously	  if	  chains	  are	  transferred	  en	  bloc.	  Therefore,	  with	  sufficient	  time	  resolution	  a	  single	  encounter	  experiment	  would	  provide	  definitive	  data	  to	  distinguish	  between	  the	  alternative	  models.	  To	  achieve	  the	  necessary	  time	  resolution,	  we	  performed	  our	  single	  encounter	  reactions	  on	  a	  quench	  flow	  apparatus	  that	  allowed	  us	  to	  take	  measurements	  on	  a	  time	  scale	  ranging	  from	  10	  milliseconds	  to	  30	  seconds	  (Figure	  2.2a).	  To	  facilitate	  quantification	  of	  S2	  and	  S5	  in	  the	  CycE	  reaction,	  the	  same	  reaction	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from	  Figure	  2.2a	  was	  fractionated	  on	  a	  gel	  with	  different	  resolving	  capabilities	  (Supplementary	  Figure	  A.12).	  Three	  major	  conclusions	  arose	  from	  these	  experiments.	  First,	  the	  product	  CycE–Ub	  (S1)	  was	  formed	  starting	  at	  the	  earliest	  	  	  
	  
Figure	  2.2	  |	  Millisecond	  kinetics	  of	  a	  single	  encounter	  reaction	  reveal	  sequential	  processivity.	  
a,	  To	  achieve	  millisecond	  temporal	  resolution	  CycE	  reactions	  were	  performed	  on	  a	  quench	  flow	  apparatus	  and	  products	  were	  evaluated	  by	  SDS-­‐PAGE	  and	  phosphorimaging.	  The	  reaction	  scheme	  matched	  reaction	  2	  of	  Figure	  2.1a.	  The	  asterisk	  marks	  a	  contaminant.	  Sn	  refers	  to	  CycE	  modified	  with	  n	  ubiquitins.	  b,	  Quantification	  shows	  successively	  longer	  lag	  phases	  for	  each	  additional	  ubiquitin	  added	  in	  the	  chain.	  The	  data	  was	  fit	  using	  closed	  form	  solutions	  refined	  by	  global	  regression	  analysis	  to	  a	  model	  with	  η=1.	  The	  error	  bars	  represent	  the	  range	  of	  values,	  n=2.
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time	  points	  (10-­‐20	  milliseconds)	  without	  a	  lag	  phase,	  indicating	  that	  E2~Ub	  binding	  to	  SCF	  was	  rapid.	  This	  is	  consistent	  with	  stopped-­‐flow	  measurements	  carried	  out	  with	  SCFb-­‐TrCP	  and	  hCdc34	  (Kleiger	  et	  al.,	  2009).	  Second,	  each	  new	  ubiquitylated	  product	  appeared	  sequentially	  with	  non-­‐concurrent	  lag	  phases	  (Figure	  2.2a,	  b	  and	  Supplementary	  Figure	  A.12).	  Third,	  the	  early	  reaction	  products	  S1-­‐S3	  ‘overshot’	  their	  final	  levels,	  indicating	  that	  these	  reaction	  intermediates	  serve	  as	  templates	  for	  the	  formation	  of	  subsequent	  products,	  supporting	  the	  model	  that	  polyubiquitin	  chains	  are	  built	  from	  multiple	  transfer	  events	  (Supplementary	  Figure	  A.16).	  Combined	  with	  the	  constraints	  on	  η	  and	  φ	  calculated	  above	  as	  well	  as	  our	  direct	  evaluation	  of	  the	  Cdc34~Ub	  pool	  (Figure	  2.1g),	  these	  data	  demonstrate	  that	  the	  underlying	  kinetic	  mechanism	  of	  our	  system	  was	  principally	  derived	  from	  sequential	  transfers	  of	  single	  ubiquitins.	  	  To	  ensure	  that	  our	  conclusions	  were	  not	  an	  artifact	  of	  the	  reaction	  design,	  we	  changed	  the	  order	  of	  addition	  in	  our	  reactions.	  SCFCdc4	  was	  pre-­‐incubated	  with	  the	  ‘charged	  E2’	  mixture	  for	  2	  minutes	  (in	  which	  case	  89%	  of	  Cdc34	  is	  present	  in	  thioesterified	  form;	  Figure	  2.1g)	  and	  reactions	  were	  initiated	  by	  combining	  with	  radiolabeled	  CycE.	  Products	  appeared	  following	  non-­‐concurrent	  lag	  phases	  of	  increasing	  duration	  (Figure	  2.2c),	  analogous	  to	  that	  observed	  when	  the	  reaction	  was	  initiated	  by	  addition	  of	  Cdc34~Ub	  to	  CycE	  prebound	  to	  SCFCdc4	  (Figure	  2.2a).	  Thus,	  regardless	  of	  whether	  CycE	  first	  encountered	  Cdc34~Ub–SCF	  or	  Cdc34~Ub	  encountered	  CycE–SCF,	  single	  ubiquitins	  were	  transferred	  to	  substrate	  in	  a	  sequential	  manner.	  Interestingly,	  reactions	  initiated	  by	  addition	  of	  CycE	  were	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delayed	  compared	  with	  those	  initiated	  by	  addition	  of	  Cdc34~Ub,	  indicating	  that	  Cdc34~Ub	  productively	  associates	  with	  SCFCdc4	  faster	  than	  does	  CycE.	  	  
SCFβ-­‐TrCP	  is	  sequentially	  processive	  	  We	  next	  sought	  to	  test	  whether	  the	  sequential	  processive	  chain	  assembly	  we	  observed	  for	  SCFCdc4	  is	  unique	  or	  illuminates	  a	  general	  principle	  of	  SCF	  ubiquitin	  ligase	  mechanism.	  To	  address	  this	  issue,	  we	  evaluated	  ubiquitylation	  of	  a	  phosphopeptide	  derived	  from	  β-­‐Catenin	  (β-­‐Cat)	  by	  its	  cognate	  E2-­‐E3	  complex,	  hCdc34	  and	  human	  SCFb-­‐TrCP.	  Nedd8	  conjugated	  E3	  (N8-­‐SCFβ-­‐TrCP)	  was	  used	  for	  these	  experiments,	  because	  prior	  work	  demonstrated	  a	  potent	  stimulation	  of	  β-­‐Cat	  ubiquitylation	  upon	  Nedd8	  conjugation	  (Saha	  and	  Deshaies,	  2009).	  As	  was	  seen	  with	  CycE–SCFCdc4,	  β-­‐Cat	  was	  rapidly	  modified	  by	  N8-­‐SCFβ-­‐TrCP	  and	  it	  was	  not	  possible	  to	  resolve	  intermediates	  in	  chain	  assembly	  by	  manual	  mixing4	  (Figure	  2.3a).	  Quantification	  of	  product	  distribution	  λβ-­‐Cat	  revealed	  that	  6%	  of	  β-­‐Cat	  molecules	  were	  modified	  in	  a	  single	  encounter	  with	  N8-­‐SCFβ-­‐TrCP,	  of	  which	  85%	  received	  ≥	  4	  ubiquitins	  (Figure	  2.3b	  and	  Supplementary	  Figure	  A.2).	  Distribution	  analysis	  of	  λβ-­‐Cat	  (Figure	  2.3c)	  and	  kinetic	  resolution	  of	  β-­‐Cat	  ubiquitylation	  by	  quench-­‐flow	  (Figure	  2.3d,	  e)	  revealed	  sequential	  appearance	  of	  intermediates	  analogous	  to	  those	  observed	  with	  CycE	  ubiquitylation	  by	  SCFCdc4.	  Although	  the	  general	  behavior	  of	  SCFCdc4	  and	  N8-­‐SCFβ-­‐TrCP	  were	  similar,	  the	  enzymes	  differed	  in	  the	  extent	  to	  which	  they	  converted	  bound	  substrate	  to	  product	  and	  elongated	  ubiquitin	  chains.	  Using	  a	  kinetic	  model	  in	  which	  monoubiquitin	  composed	  100%	  of	  η,	  we	  were	  able	  to	  employ	  methods	  borrowed	  from	  the	  study	  of	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nucleic	  acid	  polymerases	  (Kati	  et	  al.,	  1992)	  to	  extrapolate	  estimates	  for	  the	  individual	  reaction	  and	  dissociation	  rate	  constants	  from	  our	  single	  encounter	  quench-­‐flow	  experiments	  (Figure	  2.4,	  Supplementary	  Figure	  A.13-­‐15).
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Figure	  2.3	  |	  Human	  Cdc34-­‐SCFβ-­‐TrCP	  is	  sequentially	  processive.	  a,	  same	  as	  Figure	  2.1a,	  except	  that	  human	  Cdc34	  and	  Nedd8-­‐conjugated	  SCFb-­‐TrCP	  were	  assayed	  with	  32P-­‐labeled	  b-­‐Cat	  substrate.	  b,	  Product	  distribution	  (lb-­‐Cat)	  was	  quantified	  as	  in	  Figure	  2.1b.	  Error	  bars:	  +/-­‐	  SD,	  n=3.	  c,	  The	  Poisson	  distribution	  of	  φ	  using	  λβ-­‐Cat	  that	  deviated	  the	  most	  from	  φ(1)=100%	  within	  our	  set	  error	  bounds	  with	  α=0.2.	  d,	  β-­‐Cat	  reactions	  with	  the	  scheme	  of	  reaction	  2	  (Figure	  2.1a)	  performed	  on	  a	  quench	  flow	  apparatus.	  e,	  Quantification	  shows	  successively	  lengthening	  lag	  phases	  for	  each	  additional	  ubiquitin	  added	  in	  the	  chain.	  The	  data	  was	  fit	  as	  in	  Figure	  2.2b.	  	  	  	  
Discussion	  
Functional	  implications	  of	  our	  model	  The	  model	  shown	  in	  Figure	  2.4	  reveals	  the	  kinetic	  basis	  of	  processive	  polyubiquitin	  chain	  synthesis	  by	  budding	  yeast	  Cdc34-­‐SCFCdc4	  and	  human	  Cdc34-­‐SCFβ-­‐TrCP	  and	  accounts	  for	  the	  differences	  in	  their	  behavior.	  Most	  encounters	  of	  substrate	  and	  SCF	  are	  unproductive	  because	  koff	  is	  faster	  than	  kUb1.	  This	  is	  particularly	  exaggerated	  for	  b-­‐Cat	  owing	  to	  its	  low	  value	  for	  kUb1.	  Once	  a	  single	  ubiquitin	  is	  attached,	  the	  majority	  of	  substrates	  are	  committed	  to	  polyubiquitylation	  due	  to	  the	  drastic	  increase	  in	  kUb2	  relative	  to	  a	  nearly	  constant	  koff.	  This	  gives	  rise	  to	  the	  high	  percentage	  of	  modified	  substrates	  with	  four	  or	  more	  ubiquitins	  in	  their	  chain	  (68%	  for	  CycE	  and	  85%	  for	  β-­‐Cat).	  The	  overall	  chain	  length	  is	  limited	  by	  the	  progressive	  decrease	  in	  transfer	  rates	  (kUbn)	  as	  the	  chain	  becomes	  longer	  matched	  against	  the	  relatively	  constant	  rate	  at	  which	  product	  intermediates	  dissociate.	  This	  reduction	  in	  transfer	  rate	  most	  likely	  arises	  because	  the	  distal	  end	  of	  the	  flexible	  chain	  samples	  a	  progressively	  larger	  volume	  as	  it	  increases	  in	  length	  (Petroski	  et	  al.,	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2006).	  The	  longer	  chains	  on	  β-­‐Cat	  are	  a	  result	  of	  a	  less	  dramatic	  decline	  in	  kUbn	  after	  the	  second	  	  
	  
Figure	  2.4	  |	  Kinetic	  basis	  for	  Cdc34-­‐SCF	  processivity.	  The	  millisecond	  kinetics	  of	  a	  single	  encounter	  reaction	  were	  fit	  to	  a	  sequential	  model	  revealing	  estimates	  for	  individual	  transfer	  and	  dissociation	  rates	  for	  each	  intermediate	  in	  the	  generation	  of	  polyubiquitylated	  CycE	  (blue	  numbers)	  and	  β-­‐Cat	  (red	  numbers)	  products.	  The	  percentages	  listed	  above	  or	  below	  each	  product	  were	  the	  percentages	  from	  the	  final	  product	  distributions	  (λ)	  shown	  in	  Figures	  2.1b	  and	  2.3b.	  	  ubiquitin	  is	  attached.	  We	  do	  not	  understand	  the	  basis	  for	  this	  difference.	  Meanwhile,	  the	  constant	  rate	  of	  dissociation	  for	  both	  CycE	  and	  β-­‐Cat	  implies	  that	  ubiquitin	  chains	  of	  increasing	  length	  do	  not	  change	  the	  intrinsic	  affinity	  of	  these	  substrates	  for	  SCF.	   Casual	  inspection	  of	  our	  model	  suggests	  that	  modest	  changes	  in	  the	  ratio	  
kUb1/koff	  for	  the	  first	  step	  would	  substantially	  alter	  the	  fraction	  of	  substrate	  that	  acquires	  a	  chain	  of	  ≥	  4	  ubiquitins	  in	  a	  single	  encounter	  with	  SCF.	  This	  in	  turn	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provides	  a	  simple	  basis	  for	  SCF	  to	  modulate	  a	  substrate’s	  degradation	  half-­‐life	  (i.e.,	  the	  larger	  koff	  is	  or	  smaller	  kUb1	  is,	  the	  lower	  the	  probability	  that	  a	  substrate	  is	  modified	  in	  a	  single	  encounter	  with	  SCF,	  which	  would	  translate	  to	  a	  longer	  half-­‐life).	  Comparison	  of	  CycE	  and	  b-­‐Cat,	  which	  have	  distinct	  kUb1/koff	  ratios,	  underscores	  how	  the	  efficiency	  and	  pattern	  of	  substrate	  ubiquitylation	  can	  be	  tuned	  by	  these	  parameters.	  Despite	  these	  differences,	  it	  is	  remarkable	  how	  similar	  the	  reaction	  parameters	  are	  for	  two	  different	  enzymes	  from	  organisms	  separated	  by	  over	  1	  billion	  years	  of	  evolution.	  In	  both	  cases	  koff	  	  was	  ~	  0.4	  sec-­‐1	  and	  the	  fastest	  rate	  of	  ubiquitin	  chain	  elongation	  was	  4-­‐5	  sec-­‐1.	  This	  suggests	  that	  true	  substrates	  are	  tuned	  to	  dissociate	  within	  a	  few	  seconds	  and	  that	  a	  transfer	  rate	  of	  5	  sec-­‐1	  may	  be	  imposed	  by	  a	  conserved	  rate-­‐limiting	  step.	  It	  will	  be	  of	  great	  interest	  to	  determine	  what	  molecular	  event	  enforces	  this	  speed	  limit.	  We	  conclude	  that	  polyubiquitin	  chains	  are	  built	  on	  SCF	  substrates	  by	  sequential	  transfers	  of	  single	  ubiquitins.	  We	  establish	  a	  mechanistic	  framework	  that	  can	  be	  applied	  to	  other	  CRLs	  and	  RING	  ubiquitin	  ligases	  to	  obtain	  individual	  rate	  constants	  for	  substrate	  dissociation	  and	  ubiquitin	  transfer	  at	  each	  step	  in	  the	  process	  of	  chain	  assembly.	  Our	  model	  indicates	  that	  the	  processivity,	  efficiency,	  and	  pattern	  of	  ubiquitylation	  is	  governed	  by	  the	  sharp	  discontinuity	  in	  rates	  between	  the	  first	  transfer	  and	  subsequent	  transfers,	  contrasted	  with	  the	  shared	  dissociation	  rate	  among	  substrate	  and	  product	  intermediates.	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Methods	  
Methods	  summary	  
Proteins	  CycE	  and	  β-­‐Cat	  phosphopeptide	  were	  purchased	  from	  New	  England	  Peptide.	  Ubiquitin	  and	  K48	  diubiquitin	  were	  purchased	  from	  Boston	  Biochem.	  Uba1	  and	  SCFCdc4	  were	  prepared	  and	  purified	  as	  described	  (Petroski	  and	  Deshaies,	  2005b).	  Full-­‐length	  yeast	  Cdc34	  was	  purified	  as	  described	  (Feldman	  et	  al.,	  1997).	  His7-­‐Rub1	  was	  purified	  from	  E.	  coli	  inclusion	  bodies	  (Saha	  and	  Deshaies,	  2008)	  and	  human	  E1,	  UbcH3B	  (hCdc34),	  and	  Nedd8-­‐SCFβ-­‐TrCP	  were	  prepared	  and	  purified	  as	  described	  (Saha	  and	  Deshaies,	  2008).	  Yeast	  Ubc12	  and	  Ula1–Uba3	  were	  purified	  as	  described	  (Kamura	  et	  al.,	  1999).	  Rub1,	  Ubc12,	  Ula1–Uba3,	  and	  ATP	  were	  incubated	  with	  immobilized	  SCFCdc4	  to	  make	  Rub1-­‐conjugated	  SCFCdc4.	  PKA	  was	  purchased	  from	  New	  England	  Biolabs.	  	  
Ubiquitylation	  assay	  	  CycE	  (200	  nM)	  or	  β-­‐Cat	  (2	  µM)	  was	  incubated	  with	  g-­‐[32P]-­‐ATP	  (132	  nM)	  and	  PKA	  for	  45	  minutes	  at	  30°C	  to	  make	  radiolabeled	  CycE	  or	  β-­‐Cat.	  Yeast	  ubiquitylation	  reactions	  contained	  ATP	  (2	  mM),	  ubiquitin	  (60	  µM),	  Uba1	  (0.8	  µM),	  Cdc34	  (10	  µM),	  SCFCdc4	  (150	  nM),	  and	  radiolabeled	  CycE	  (10	  nM).	  Human	  ubiquitylation	  reactions	  contained	  ATP	  (2	  mM),	  ubiquitin	  (60	  µM),	  E1	  (1	  µM),	  Cdc34	  (10	  µM),	  SCFβ-­‐TrCP	  (500	  nM),	  and	  radiolabeled	  β-­‐Cat	  (100	  nM).	  As	  indicated,	  single	  encounter	  reactions	  contained	  an	  unlabeled	  CycE	  chase	  (10	  µM)	  or	  β-­‐Cat	  chase	  (100	  µM).	  Millisecond	  reactions	  were	  performed	  on	  a	  quench	  flow	  apparatus	  (Kintek	  RQF-­‐3	  Rapid	  Quench	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Flow).	  Reactions	  contained	  a	  buffer	  previously	  described	  (Petroski	  and	  Dehsaies,	  2005c)	  at	  23°C.	  Reactions	  were	  quenched	  with	  SDS-­‐PAGE	  buffer	  with	  βME	  and	  run	  on	  20	  cm	  5-­‐20%	  tricine	  gels	  (CycE)	  or	  Glycine	  gels	  (β-­‐Cat)	  that	  were	  quantified	  with	  a	  phosphor	  screen	  (Molecular	  Devices).	  Thioester	  formation	  assays	  contained	  Cdc34	  (10	  µM),	  Uba1	  (1	  µM),	  ATP	  (2	  mM),	  ubiquitin	  or	  K48	  diubiquitin	  (15	  µM),	  and	  SCFCdc4	  (100	  nM),	  as	  indicated.	  After	  2	  minutes,	  reactions	  were	  stopped	  with	  excess	  5%	  acetic	  acid	  and	  analyzed	  on	  an	  Agilent	  LC-­‐MSD.	  
Analysis	  	  Deconvolutions	  and	  regression	  were	  performed	  in	  Matlab.	  Global	  fitting	  was	  performed	  with	  KinTek	  Global	  Kinetic	  Explorer.	  Mass	  spec	  data	  was	  processed	  using	  the	  Chemstation	  software	  package.	  
Full	  Methods	  RDB	  2289	  with	  pGEX2-­‐T	  His7-­‐Rub1	  was	  made	  by	  cloning	  a	  His7	  tag	  in	  place	  of	  the	  GST	  tag	  in	  RDB	  1436.	  To	  make	  Rub1-­‐conjugated	  SCFCdc4,	  the	  procedure	  for	  isolating	  SCFCdc4	  was	  modified	  (Petroski	  and	  Deshaies,	  2005c).	  Instead	  of	  eluting	  SCFCdc4	  from	  Py	  conjugated	  protein	  A	  beads	  after	  washing,	  50	  µM	  Rub1,	  10	  µM	  Ubc12,	  1	  µM	  Ula1–Uba3,	  and	  2	  mM	  ATP	  were	  incubated	  together	  overnight.	  The	  beads	  were	  washed	  before	  elution.	  	  	  For	  all	  reactions,	  gels	  were	  dried	  and	  exposed	  to	  Phosphor	  screens	  (Molecular	  Dynamics).	  Images	  were	  scanned	  and	  then	  quantified	  in	  ImageQuant	  using	  a	  rolling	  ball	  background	  subtraction.	  For	  each	  lane,	  every	  band	  was	  quantified	  as	  a	  percent	  of	  the	  total	  signal	  in	  all	  bands.	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The	  relationship	  between	  η,	  φ,	  and	  λ	  was	  mathematically	  analogous	  to	  the	  probability	  of	  the	  sum	  of	  multiple	  dice	  throws.	  However,	  the	  probability	  of	  throwing	  each	  number	  on	  the	  dice	  was	  a	  weighted	  normalized	  distribution	  (analogous	  to	  η)	  and	  the	  number	  of	  throws	  was	  also	  a	  weighted	  normalized	  distribution	  (analogous	  to	  φ).	  A	  distribution	  that	  is	  normalized	  sums	  to	  1.	  Thus,	  λ	  equaled	  the	  weighted	  sum	  of	  multiple	  discrete	  convolutions	  of	  η	  with	  itself	  as	  governed	  by	  φ,	  as	  shown	  by	  example	  in	  Supplementary	  Figure	  A.3.	  Knowledge	  of	  λ	  and	  η	  allowed	  us	  to	  calculate	  φ	  by	  multiple	  weighted	  deconvolutions,	  as	  shown	  by	  example	  in	  Supplementary	  Figure	  A.4.	  This	  was	  true	  for	  calculating	  η	  from	  λ	  and	  φ,	  as	  shown	  by	  example	  in	  Supplementary	  Figure	  A.5a.	  If	  we	  assigned	  a	  distribution	  to	  η,	  we	  determined	  φ	  by	  deconvolutions	  with	  λ,	  and	  vice	  versa.	  Considering	  normalized	  distributions	  of	  η	  that	  only	  contain	  η(1)	  and	  η(2),	  exponential	  distributions,	  poisson	  distributions,	  and	  normal	  distributions,	  we	  varied	  parameters	  over	  a	  wide	  range	  and	  performed	  deconvolutions,	  as	  shown	  by	  example	  in	  Supplementary	  Figure	  A.5b.	  An	  exponential	  distribution	  is	  described	  by	  a	  single	  parameter,	  here	  called	  α.	  A	  poisson	  distribution	  is	  also	  described	  by	  a	  single	  parameter,	  here	  called	  α.	  The	  normal	  distribution	  is	  described	  by	  two	  parameters,	  the	  mean	  and	  the	  standard	  deviation	  (SD).	  Parameters	  were	  varied	  starting	  at	  0	  and	  increasing	  by	  step	  sizes	  of	  0.1	  until	  parameters	  equaled	  10.	  For	  the	  normal	  distribution,	  each	  value	  of	  the	  mean	  was	  held	  constant	  while	  the	  SD	  was	  varied.	  We	  sought	  the	  distribution	  which	  deviated	  most	  from	  η(1)=100%	  whose	  φ	  did	  not	  contain	  values	  >	  1	  or	  <	  0,	  and	  that	  when	  convoluted	  with	  φ,	  the	  sum	  of	  λ	  fell	  within	  0.95	  and	  1.05,	  or	  an	  error	  rate	  of	  ±	  5%	  was	  found.	  This	  was	  repeated	  for	  φ.	  These	  distributions	  are	  shown	  in	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Supplementary	  Figures	  A.6	  and	  A.7.	  Random	  distributions	  were	  also	  considered	  (data	  not	  shown).	  For	  mass	  spectrometry	  analysis,	  Uba1	  (1	  μM),	  Cdc34-­‐Δ270	  (10	  μM),	  and	  ubiquitin	  or	  K48	  linked	  di-­‐ubiquitin	  (15	  μM,	  Boston	  Biochem)	  were	  incubated	  for	  2	  minutes	  in	  reaction	  buffer	  (30	  mM	  Tris,	  pH	  7.5,	  100	  mM	  NaCl,	  5	  mM	  MgCl2,	  2	  mM	  DTT,	  and	  2	  mM	  ATP)	  in	  a	  volume	  of	  10	  µl,	  both	  in	  the	  presence	  and	  absence	  of	  SCF	  (100	  nM).	  	  Reactions	  were	  quenched	  by	  the	  addition	  of	  90	  µl	  5	  %	  acetic	  acid.	  	  Quenching	  was	  verified	  by	  an	  order	  of	  addition	  reaction	  where	  E1	  was	  left	  out	  of	  the	  initial	  incubation	  and	  was	  added	  following	  quenching.	  	  This	  resulted	  in	  100%	  quenching	  of	  the	  thioester	  charging	  reaction.	  	  Separation	  of	  E2	  thioesters	  in	  the	  presence	  of	  SCF	  was	  accomplished	  by	  the	  addition	  of	  100	  mM	  DTT	  after	  the	  2	  minute	  incubation	  period.	  	  The	  DTT	  was	  incubated	  with	  the	  reaction	  mixture	  for	  5	  minutes,	  followed	  by	  the	  addition	  of	  90	  µl	  of	  5	  %	  acetic	  acid.	  Detection	  of	  proteins	  was	  carried	  out	  on	  an	  Agilent	  LC-­‐MSD	  (Agilent,	  Palo	  Alto,	  CA).	  	  Mass	  spectra	  were	  acquired	  in	  positive-­‐ion	  mode,	  scanning	  from	  500	  to	  1700	  m/z.	  	  The	  electrospray	  voltage	  was	  set	  to	  4	  kV	  and	  the	  gas	  temperature	  in	  the	  spray	  chamber	  was	  maintained	  at	  350°C.	  	  A	  stationary	  phase,	  Zorbax	  300SB	  C3	  150×2.1-­‐mm	  column	  was	  used	  for	  separation	  (Agilent;	  Bodman,	  Aston,	  PA).	  	  Mobile	  phase	  A	  was	  0.2%	  formic	  acid	  and	  mobile	  phase	  B	  was	  0.2%	  formic	  acid,	  10%	  methanol,	  and	  90%	  acetonitrile.	  The	  flow	  rate	  was	  0.200	  ml/min.	  After	  a	  25	  min	  delay,	  the	  effluent	  was	  directed	  into	  the	  mass	  spectrometer.	  	  Linear	  gradients	  started	  with	  5%	  mobile	  phase	  B	  and	  finished	  at	  95%	  from	  25	  –	  50	  min.	  	  Data	  were	  processed	  using	  the	  chemstation	  software	  package.	  The	  sequence	  of	  yeast	  Cdc34-­‐Δ270	  contains	  the	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amino	  acids	  from	  positions	  1	  to	  270	  of	  the	  yeast	  Cdc34	  sequence	  followed	  by	  the	  sequence	  ARPLHHHHHH,	  yielding	  a	  theoretical	  molecular	  mass	  of	  32,245	  Daltons.	  	  The	  theoretical	  mass	  of	  Cdc34-­‐Δ270	  thioesterified	  with	  ubiquitin	  (40,792)	  was	  calculated	  by	  summing	  the	  masses	  of	  Cdc34-­‐Δ270	  (32,245)	  and	  ubiquitin	  (8,565)	  and	  subtracting	  the	  mass	  of	  a	  water	  molecule,	  which	  is	  lost	  during	  formation	  of	  the	  thioester	  bond.	  	  	  	  For	  CycE	  global	  fitting	  with	  KinTek	  Global	  Kinetic	  Explorer,	  the	  average	  of	  two	  independent	  experiments	  was	  fit	  to	  a	  model	  with	  η=1,	  and	  the	  fit	  for	  k1	  through	  k4	  used	  the	  normalized	  option,	  while	  the	  rest	  of	  the	  rate	  constants	  did	  not.	  For	  β-­‐Cat	  global	  fitting,	  rate	  constants	  were	  fit	  without	  normalization.	  To	  improve	  fitting,	  neighboring	  rate	  constants	  were	  constrained	  by	  the	  end	  point.	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Chapter	  3:	  
CAND1	  Functions	  as	  an	  Fbox	  Exchange	  Factor	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Abstract	  
The	  modular	  design	  of	  the	  multi-­‐subunit	  SCF	  ubiquitin	  ligases	  allows	  for	  recognition	  of	  a	  diverse	  set	  of	  target	  proteins.	  However,	  how	  SCF	  complex	  formation	  is	  regulated	  remains	  unclear.	  Cullin-­‐associated	  and	  neddylation-­‐dissociated	  protein	  1	  (CAND1)	  is	  a	  Cul1-­‐associated	  protein	  that	  has	  been	  reported	  to	  inhibit	  SCF	  complex	  formation.	  Nonetheless,	  the	  function	  of	  CAND1	  remains	  elusive	  given	  the	  lack	  of	  a	  mechanistic	  framework	  for	  each	  of	  its	  reported	  activities.	  Here	  we	  present	  a	  novel	  FRET	  assay	  that	  enables	  real-­‐time	  measurements	  of	  binding	  dynamics	  of	  the	  SCFFbxw7	  complex.	  We	  find	  that	  CAND1	  is	  able	  to	  actively	  remove	  Fbxw7/Skp1	  from	  Cul1/Rbx1	  by	  changing	  the	  dissociation	  rate	  of	  the	  complex	  a	  million-­‐fold,	  yet	  CAND1	  does	  not	  affect	  the	  assembly	  rate	  of	  SCF	  Fbxw7.	  This	  activity	  is	  abolished	  when	  Cul1	  is	  neddylated.	  Experiments	  show	  that	  CAND1	  accelerates	  the	  rate	  at	  which	  multiple	  SCF	  complexes	  can	  form.	  Thus,	  CAND1	  appears	  to	  function	  as	  an	  exchange	  factor.	  Our	  results	  serve	  as	  a	  basis	  to	  resolve	  the	  function	  of	  CAND1	  in	  vivo.	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Introduction	  
Three	  enzymes	  work	  in	  succession	  to	  covalently	  attach	  ubiquitin	  and	  ubiquitin	  chains	  to	  target	  proteins:	  a	  ubiquitin	  activating	  enzyme	  (E1),	  a	  ubiquitin	  conjugating	  enzyme	  (E2),	  and	  a	  ubiquitin	  ligase	  (E3)	  (Dye	  and	  Schulman,	  2007).	  	  The	  proteasome,	  a	  massive	  multi-­‐subunit	  protease,	  recognizes	  and	  degrades	  proteins	  attached	  with	  lysine	  48	  linked	  polyubiquitin	  chains	  containing	  at	  least	  four	  ubiquitins	  (Thrower	  et	  al.,	  2000).	  Cullin-­‐RING	  ubiquitin	  ligases	  (CRLs)	  are	  the	  largest	  family	  of	  E3s	  and	  are	  typified	  by	  the	  SCF	  complexes,	  which	  in	  humans	  are	  composed	  of	  four	  proteins:	  the	  scaffold	  Cul1,	  the	  RING	  containing	  Rbx1,	  the	  adaptor	  Skp1,	  and	  a	  substrate	  binding	  protein	  that	  contains	  the	  Fbox	  motif	  (Petroski	  and	  Deshaies,	  2005a).	  69	  proteins	  in	  the	  human	  genome	  have	  Fbox	  motifs,	  and	  42	  have	  been	  shown	  to	  form	  SCF	  complexes	  (Lee	  et	  al.,	  2011).	  Although	  this	  modular	  design	  of	  SCF	  complexes	  allows	  for	  recognition	  of	  a	  diverse	  set	  of	  target	  proteins,	  how	  SCF	  complex	  formation	  is	  regulated	  remains	  unclear.	  Cullin-­‐associated	  and	  neddylation-­‐dissociated	  protein	  1	  (CAND1)	  was	  originally	  isolated	  as	  a	  Cul1	  associated	  protein	  whose	  binding	  was	  mutually	  exclusive	  with	  the	  Fbox/Skp1	  sub-­‐complex	  (Liu	  et	  al.,	  2002;	  Zheng	  et	  al.,	  2002).	  CAND1’s	  dissociation	  from	  Cul1/Rbx1	  was	  coupled	  to	  the	  attachment	  of	  the	  ubiquitin-­‐like	  protein	  Nedd8	  to	  lysine	  720	  of	  Cul1	  (Liu	  et	  al.,	  2002;	  Zheng	  et	  al.,	  2002).	  Neddylation	  of	  Cul1	  activates	  SCF	  complexes	  by	  inducing	  a	  major	  conformational	  rearrangement	  in	  Cul1	  and	  stimulates	  ubiquitin	  transfer	  from	  associated	  E2s	  to	  Fbox-­‐bound	  target	  substrates	  (Saha	  and	  Deshaies,	  2008;	  Duda	  et	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al.,	  2008).	  In	  vitro,	  CAND1	  acts	  as	  an	  inhibitor	  of	  CRL	  ubiquitylation	  and	  neddylation	  (Liu	  et	  al.,	  2002;	  Zheng	  et	  al.,	  2002;	  Siergiejuk	  et	  al.,	  2009).	  For	  these	  reasons,	  CAND1	  was	  recognized	  as	  a	  negative	  regulator	  of	  SCF	  complex	  assembly.	  However,	  genetic	  evidence	  indicates	  that	  CAND1	  acts	  as	  a	  positive	  regulator	  of	  CRL	  function	  in	  
vivo.	  First,	  knock	  down	  of	  CAND1	  by	  siRNA	  stimulates	  assembly	  of	  Cul3Keap1	  but	  reduces	  its	  ability	  to	  target	  Nrf2	  for	  degradation	  (Lo,	  Hannink	  2006).	  Second,	  siRNA	  against	  CAND1	  stabilizes	  the	  SCFSkp2	  substrate	  p27	  (Zheng	  et	  al.,	  2002).	  Lastly,	  mutations	  in	  CAND1	  in	  plants	  disrupt	  auxin	  and	  gibberellin	  signaling	  through	  stabilization	  of	  the	  SCFTir1	  substrate	  IAA7	  and	  the	  SCFSLY1	  substrate	  RGA,	  respectively	  (Chuang	  et	  al.,	  2004;	  Feng	  et	  al.,	  2004).	  These	  observations	  gave	  rise	  to	  the	  idea	  that	  CAND1-­‐mediated	  CRL	  adaptor	  recycling	  was	  crucial	  for	  proper	  CRL	  function	  (Liu	  et	  al.,	  2002;	  Cope	  and	  Deshaies	  2003;	  Schmidt	  et	  al.,	  2009;	  Zhang	  et	  al.,	  2008).	  Furthermore,	  the	  role	  of	  CAND1	  was	  envisioned	  to	  be	  coupled	  to	  cycles	  of	  neddylation	  and	  de-­‐neddylation	  in	  which	  CAND1	  sequesters	  a	  substantial	  fraction	  of	  naked	  Cul1/Rbx1	  devoid	  of	  Fbox/Skp1	  and	  Nedd8	  (Deshaies	  and	  Cope,	  2003).	  However,	  a	  recent	  analysis	  of	  the	  CRL	  network	  in	  vivo	  found	  that	  in	  the	  absence	  of	  neddylation	  CAND1	  does	  not	  sequester	  Cul1/Rbx1	  away	  from	  Fbox/Skp1	  complexes	  (Bennett	  et	  al.,	  2010).	  	  In	  order	  to	  reconcile	  the	  above	  observations,	  we	  have	  constructed	  the	  first	  kinetic	  framework	  for	  the	  assembly	  of	  a	  CRL	  complex	  in	  vitro	  using	  a	  novel	  FRET	  assay	  that	  enables	  real-­‐time	  measurements	  of	  SCFFbxw7	  binding	  dynamics.	  CAND1’s	  perturbations	  of	  these	  dynamics	  reveal	  that	  CAND1	  acts	  as	  a	  Nedd8-­‐dependent	  Fbox	  exchange	  factor.	  Armed	  with	  this	  knowledge,	  we	  establish	  a	  biochemical	  assay	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involving	  multiple	  Fboxes	  that	  reconstitutes	  the	  activator	  function	  of	  CAND1	  in	  vitro	  with	  pure	  components.	  Our	  biochemical	  results	  show	  for	  the	  first	  time	  that	  CAND1	  is	  sufficient	  for	  CRL	  adaptor	  cycling	  in	  vitro	  and	  that	  this	  activity	  leads	  directly	  to	  CAND1-­‐mediated	  stimulation	  of	  CRL	  ubiquitin	  ligase	  activity.	  Further,	  CAND1’s	  exchange	  factor	  activity	  represents	  a	  novel	  form	  of	  regulation	  for	  protein-­‐protein	  interactions	  that	  thus	  far	  has	  only	  been	  seen	  for	  protein-­‐small-­‐molecule	  interactions,	  such	  as	  the	  GEFs.	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Results	  
Intrinsic	  assembly	  properties	  of	  SCFFbxw7	  To	  characterize	  the	  assembly	  properties	  of	  SCF	  complexes,	  we	  developed	  a	  real-­‐time	  assay	  based	  on	  FRET	  that	  monitors	  the	  binding	  dynamics	  between	  the	  sub-­‐complexes	  of	  Fbox/Skp1	  and	  Cul1/Rbx1.	  The	  C-­‐terminus	  of	  the	  Fbox	  protein	  Fbxw7	  was	  fused	  to	  the	  peptide	  sequence	  LPETGG	  and	  co-­‐expressed	  recombinantly	  with	  Skp1.	  After	  purification,	  we	  reacted	  the	  complex	  with	  the	  trans-­‐peptidase	  enzyme	  Sortase	  in	  the	  presence	  of	  the	  peptide	  GGGGK-­‐TAMRA,	  producing	  Fbxw7	  covalently	  labeled	  with	  TAMRA	  (Popp	  et	  al.,	  2009).	  The	  trans-­‐peptidation	  reaction	  was	  efficient	  and	  did	  not	  compromise	  ubiquitylation	  activity	  (Supplementary	  Figure	  B.1a).	  We	  observed	  FRET	  between	  Fbxw7-­‐TAMRA/Skp1	  and	  Cul1	  fused	  N	  terminally	  to	  cyan	  fluorescent	  protein	  (CFP)	  co-­‐expressed	  with	  Rbx1	  (Figure	  3.1a).	  The	  rate	  of	  complex	  assembly	  was	  determined	  by	  monitoring	  the	  changes	  of	  donor	  Cul1	  NTD	  CFP/Rbx1	  fluorescence	  when	  mixed	  with	  varying	  concentrations	  of	  Fbxw7	  TAMRA/Skp1	  in	  a	  stop	  flow	  apparatus.	  The	  change	  in	  signal	  was	  fit	  to	  single	  exponential	  curves	  (Figure	  3.1b).	  The	  change	  in	  the	  observed	  rate	  of	  the	  reaction	  as	  a	  function	  of	  acceptor	  concentration	  revealed	  a	  fast	  binding	  rate	  of	  4	  x	  106	  M-­‐1	  s-­‐1	  (Figure	  3.1c).	  The	  FRET	  observed	  in	  our	  assay	  could	  be	  chased	  away	  by	  excess	  non-­‐fluorescent	  Fbox/Skp1	  (Figure	  3.1d).	  Using	  this	  chase	  assay,	  we	  measured	  a	  dissociation	  rate	  for	  SCFFbxw7	  of	  9	  x	  10-­‐7	  s-­‐1	  or	  0.5	  week-­‐1	  (Figure	  3.1e).	  These	  measurements	  revealed	  an	  extraordinarily	  tight	  complex	  with	  a	  Kd	  of	  2	  x	  10-­‐13	  M	  (200	  fM).	  Neddylation	  of	  Cul1	  did	  not	  affect	  the	  FRET	  efficiency	  in	  our	  assay,	  the	  association	  rate,	  nor	  the	  dissociation	  rate	  of	  SCF	  complex	  assembly	  (Figure	  3.1c	  &	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Supplemental	  Figure	  B.1b-­‐d).	  To	  extend	  our	  finding	  to	  other	  SCF	  complexes	  we	  attempted	  to	  make	  FRET	  assays	  using	  a	  similar	  strategy	  for	  Skp2	  and	  β-­‐TrCP,	  but	  were	  unsuccessful	  (data	  not	  shown).	  In	  lieu	  of	  direct	  binding	  data,	  we	  designed	  an	  assay	  that	  used	  Fbxw7-­‐TAMRA/Skp1	  as	  the	  chase	  and	  monitored	  gain	  of	  FRET	  (Supplemental	  Figure	  B.1e).	  An	  upper	  limit	  of	  5	  x	  10-­‐5	  s-­‐1	  for	  the	  dissociation	  rate	  was	  found	  for	  SCFβ-­‐TrCP	  (Fig.	  1f).	  	  
	  
Figure	  3.1	  |	  FRET	  Reveals	  Properties	  of	  SCF	  Assembly.	  a,	  Fluorescence	  emission	  spectra	  from	  excitation	  at	  430	  nm	  of	  70	  nM	  Cul1	  NTD	  CFP/Rbx1,	  70	  nM	  Fbxw7-­‐TAMRA/Skp1,	  a	  mixture	  of	  the	  two,	  or	  buffer	  alone	  reveals	  FRET	  with	  30%	  efficiency	  upon	  complex	  formation.	  Normalized	  to	  peak	  donor	  emission	  at	  478	  nm.	  b,	  The	  change	  in	  donor	  fluorescence	  versus	  time	  in	  a	  stop	  flow	  apparatus	  with	  5	  nM	  Cul1	  NTD	  CFP/Rbx1	  and	  varying	  concentrations	  of	  Fbxw7	  TAMRA/Skp1.	  Signal	  changes	  were	  fit	  to	  single	  exponential	  curves.	  c,	  The	  rate	  of	  signal	  change	  in	  b	  versus	  the	  concentration	  of	  Fbxw7	  TAMRA/Skp1.	  Fitting	  the	  data	  to	  (kobs	  =	  kon*[Fbxw7]	  +	  koff)	  gave	  kon	  of	  4	  x	  106	  M-­‐1	  s-­‐1	  regardless	  of	  Cul1’s	  neddylation	  status.	  Error	  bars:	  +/-­‐	  SD,	  n≥3.	  d,	  700	  nM	  Skp2/Skp1	  (chase)	  competes	  FRET	  away	  if	  pre-­‐incubated	  with	  70	  nM	  Fbxw7	  TAMRA/Skp1	  before,	  but	  not	  after	  addition	  of	  70	  nM	  Cul1	  
	   36	  
NTD	  CFP	  for	  5	  min.	  e,	  Fluorescence	  emission	  at	  478	  nm	  versus	  time	  after	  addition	  of	  chase	  to	  pre-­‐incubated	  Cul1	  NTD	  CFP/Rbx1	  and	  Fbxw7	  TAMRA/Skp1	  normalized	  to	  peak	  donor	  emission	  in	  d.	  Single	  exponential	  fit	  with	  a	  fixed	  end	  point	  of	  1	  gave	  koff	  of	  8.5	  x	  10-­‐7	  s-­‐7.	  Kd	  is	  thus	  2	  x	  10-­‐13	  M.	  Error	  bars:	  +/-­‐	  SD,	  n=3.	  f,	  Fluorescence	  emission	  at	  478	  nm	  versus	  time	  after	  addition	  of	  210	  nM	  Fbxw7	  TAMRA/Skp1	  to	  70	  nM	  Cul1	  NTD	  CFP	  pre-­‐incubated	  with	  70	  nM	  β-­‐TrCP.	  A	  single	  exponential	  fit	  gave	  koff	  of	  5	  x	  10-­‐5	  s-­‐1.	  Error	  bars:	  range	  of	  values,	  n=2.	  
	  
CAND1	  increases	  off	  rate	  of	  Fbxw7/Skp1	  It	  has	  been	  reported	  that	  Fbox/Skp1	  and	  CAND1	  antagonize	  each	  other’s	  binding	  to	  Cul1/Rbx1	  (Goldenberg	  et	  al.,	  2004;	  Siergiejuk	  et	  al.,	  2009).	  Despite	  several	  attempts,	  we	  failed	  to	  create	  a	  fluorescent	  assay	  that	  measured	  the	  binding	  of	  CAND1	  to	  Cul1/Rbx1	  (data	  not	  shown).	  Thus,	  to	  measure	  directly	  CAND1’s	  affect	  on	  SCF	  assembly,	  we	  added	  two-­‐fold	  excess	  CAND1	  to	  a	  preformed	  SCFFbxw7	  complex	  displaying	  FRET.	  We	  observed	  a	  significantly	  reduced	  amount	  of	  FRET	  after	  five	  minutes,	  indicating	  that	  CAND1	  interferes	  with	  Fbxw7/Skp1	  binding	  to	  Cul1/Rbx1	  (Figure	  3.2a).	  To	  ensure	  that	  this	  observation	  was	  not	  an	  artifact	  of	  our	  FRET	  assay,	  we	  repeated	  this	  measurement	  but	  included	  a	  chase	  of	  unlabeled	  Fbox/Skp1	  when	  we	  added	  CAND1.	  The	  FRET	  signal	  was	  further	  reduced	  to	  no	  FRET	  in	  the	  same	  five	  minute	  time	  span.	  Importantly,	  when	  we	  repeated	  these	  experiments	  with	  neddylated	  Cul1,	  CAND1’s	  effect	  was	  eliminated	  (Figure	  3.2b).	  These	  observations	  are	  surprising	  for	  several	  reasons.	  First,	  the	  short	  time	  span	  used	  here	  is	  in	  direct	  contrast	  to	  the	  slow	  off	  rate	  observed	  in	  Figure	  3.1e	  indicating	  that	  CAND1	  is	  not	  acting	  as	  a	  competitive	  inhibitor	  that	  must	  wait	  for	  Fbxw7/Skp1	  to	  dissociate.	  Second,	  this	  implies	  that	  CAND1	  is	  an	  allosteric	  regulator	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of	  SCF	  complexes	  that	  actively	  remodels	  them	  in	  the	  absence	  of	  any	  energy	  input	  such	  as	  ATP.	  Third,	  given	  that	  CAND1	  has	  two	  major	  binding	  sites	  on	  the	  N-­‐terminus	  (NTD)	  and	  the	  C-­‐terminus	  (CTD)	  of	  Cul1,	  these	  results	  suggest	  that	  disruption	  of	  CAND1’s	  CTD	  binding	  site	  by	  the	  Nedd8-­‐induced	  conformational	  change	  dramatically	  affects	  its	  ability	  to	  regulate	  Fbxw7/Skp1	  binding	  at	  Cul1’s	  NTD	  (Goldenberg	  et	  al.,	  2004;	  Duda	  et	  al.,	  2008).	  This	  is	  especially	  intriguing	  given	  that	  the	  NTD	  of	  Cul1	  when	  bound	  to	  CAND1	  or	  Fbox/Skp1	  is	  nearly	  structurally	  identical.	  	  To	  determine	  the	  mechanistic	  basis	  of	  CAND1’s	  ability	  to	  remodel	  SCF	  complexes	  we	  measured	  the	  loss	  of	  FRET	  in	  real	  time	  upon	  addition	  of	  CAND1	  to	  a	  preformed	  complex	  in	  a	  stop	  flow	  apparatus	  (Figure	  3.2c).	  This	  loss	  of	  FRET	  fit	  well	  to	  a	  single	  exponential	  curve.	  Titration	  of	  CAND1	  in	  this	  assay	  revealed	  increasingly	  rapid	  rates	  of	  SCF	  complex	  dissociation	  that	  followed	  saturation	  kinetics	  with	  a	  maximum	  rate	  of	  1.3	  s-­‐1	  and	  a	  half	  maximal	  concentration	  (Km)	  of	  26	  nM	  (Figure	  3.2d).	  To	  eliminate	  interference	  in	  our	  signal	  from	  re-­‐association	  of	  Fbxw7/Skp1	  to	  Cul1/Rbx1,	  we	  repeated	  our	  measurements	  with	  Fbox/Skp1	  chase	  in	  the	  reaction	  (Figure	  3.2d).	  The	  maximal	  rate	  of	  CAND1	  dependent	  dissociation	  remained	  unchanged	  while	  the	  Km	  increased	  to	  53	  nM	  (Figure	  3.2d).	  In	  agreement	  with	  previous	  results,	  SCF	  complexes	  formed	  with	  neddylated	  Cul1	  showed	  no	  dissociation	  in	  response	  to	  CAND1	  in	  this	  assay	  (Figure	  3.2d).	  However,	  when	  the	  assay	  was	  repeated	  on	  longer	  timescales,	  CAND1	  had	  a	  modest	  45-­‐fold	  effect	  on	  the	  dissociation	  rate	  if	  Cul1	  is	  neddylated	  (Figure	  3.2e).	  Three	  main	  points	  arise	  from	  this	  analysis.	  First,	  the	  saturation	  kinetics	  seen	  in	  this	  assay	  reveal	  the	  existence	  of	  a	  transient	  complex	  that	  contains	  CAND1,	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Cul1/Rbx1,	  and	  Fbxw7/Skp1.	  Second,	  the	  Km	  of	  53	  nM	  sets	  an	  upper	  limit	  on	  the	  Kd	  between	  CAND1	  and	  Cul1/Rbx1	  in	  the	  presence	  of	  Fbxw7/Skp1.	  Third,	  the	  maximal	  observed	  rate	  of	  1.3	  s-­‐1	  represents	  the	  rate	  of	  Fbxw7/Skp1	  dissociation	  from	  the	  transient	  complex	  containing	  CAND1.	  The	  difference	  between	  the	  off	  rate	  of	  Fbxw7/Skp1	  from	  Cul1/Rbx1	  with	  and	  with	  out	  CAND1	  is	  extraordinary.	  CAND1	  actively	  changes	  the	  dissociation	  rate	  of	  SCFFbxw7	  a	  million-­‐fold.	  Neddylation	  of	  Cul1	  nearly	  abolishes	  the	  effect	  of	  CAND1,	  decreasing	  the	  dissociation	  rate	  of	  SCFFbxw7	  30,000	  fold	  in	  the	  presence	  of	  CAND1.	  
	  
Figure	  3.2	  |	  CAND1	  Actively	  Removes	  Fbxw7/Skp1	  By	  Altering	  Off	  Rate.	  a,	  As	  in	  Figure	  3.1a	  and	  Figure	  3.1d	  except	  with	  the	  addition	  of	  150	  nM	  CAND1.	  b,	  As	  in	  a,	  except	  using	  neddylated	  Cul1	  NTD	  CFP.	  c,	  The	  change	  in	  donor	  fluorescence	  versus	  time	  in	  a	  stop	  flow	  apparatus	  upon	  addition	  of	  150	  nM	  CAND1	  with	  50	  nM	  Cul1	  NTD	  CFP/Rbx1	  pre-­‐incubated	  with	  50	  nM	  Fbxw7	  TAMRA/Skp1.	  d,	  The	  single	  exponential	  observed	  rates	  for	  various	  CAND1	  concentrations	  mixed	  with	  5	  nM	  Cul1	  NTD	  CFP/Rbx1	  or	  5nM	  neddylated	  Cul1	  NTD	  CFP/Rbx1	  pre-­‐incubated	  with	  5	  nM	  Fbxw7	  TAMRA/Skp1.	  Chase	  indicates	  700	  nM	  Skp2/Skp1.	  Error	  bars:	  +/-­‐	  SD,	  n≥3.	  e,	  As	  in	  Figure	  3.1e	  except	  with	  150	  nM	  
	   39	  
CAND1	  and	  700	  nM	  Skp2/Skp1	  chase	  mixed	  with	  70nM	  neddylated	  Cul1	  NTD	  CFP	  pre-­‐incubated	  with	  70	  nM	  Fbxw7	  TAMRA/Skp1.	  Error	  bars:	  range	  of	  values,	  n=2.	  f,	  As	  in	  Figure	  3.1c,	  except	  with	  150	  nM	  CAND1	  pre-­‐incubated	  with	  5	  nM	  Cul1	  NTD	  CFP/Rbx1.	  Error	  bars:	  +/-­‐	  SD,	  n≥3.	  
	  
CAND1	  only	  affects	  SCF	  dissociation	  The	  above	  data	  are	  consistent	  with	  previous	  observations	  that	  lead	  to	  the	  conclusion	  that	  CAND1	  functions	  as	  a	  neddylation	  dependent	  inhibitor	  of	  SCF	  complex	  formation.	  Yet,	  the	  dramatic	  increase	  in	  off-­‐rate	  measured	  above	  is	  not	  itself	  proof	  that	  CAND1	  is	  an	  inhibitor.	  To	  determine	  directly	  if	  CAND1	  is	  an	  inhibitor,	  we	  measured	  the	  association	  rate	  of	  Fbxw7	  TAMRA/Skp1	  and	  Cul1	  NTD	  CFP/Rbx1	  pre-­‐incubated	  with	  a	  saturating	  concentration	  of	  CAND1.	  Shockingly,	  CAND1	  did	  not	  affect	  the	  association	  rate	  of	  SCFFbxw7	  (Figure	  3.2f).	  To	  better	  understand	  how	  CAND1	  specifically	  modulates	  the	  dissociation	  rate	  of	  SCF	  complexes	  and	  not	  the	  associate	  rate	  we	  took	  advantage	  of	  the	  observation	  that	  CAND1	  inhibits	  neddylation	  of	  Cul1/Rbx1	  in	  vitro,	  and	  that	  this	  inhibition	  is	  relieved	  by	  Fbox/Skp1	  complexes	  (Siergiejuk	  et	  al.,	  2009).	  We	  designed	  an	  assay	  using	  radiolabeled	  Cul1	  to	  follow	  neddylation	  in	  real	  time.	  Near	  stoichiometric	  amounts	  of	  CAND1	  inhibited	  neddylation	  of	  Cul1.	  Three	  different	  Fbox/Skp1	  complexes	  suppressed	  CAND1’s	  ability	  to	  inhibit	  neddylation	  in	  a	  manner	  dependent	  on	  acidic	  loops	  in	  Skp1	  that	  are	  unnecessary	  for	  ubiquitylation	  (Figure	  3.3a	  &	  Supplementary	  Figure	  B.1f).	  	  	  Three	  major	  points	  emerge	  from	  these	  experiments.	  First,	  CAND1	  does	  not	  act	  as	  a	  classic	  inhibitor	  of	  SCF	  complexes	  because	  CAND1	  does	  not	  block	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Fbox/Skp1	  complexes	  from	  binding	  to	  Cul1/Rbx1.	  Second,	  Fbox/Skp1	  complexes	  have	  the	  ability	  to	  remove	  CAND1	  in	  a	  manner	  that	  is	  dependent	  on	  the	  acidic	  loops	  in	  Skp1.	  Third,	  these	  results	  suggest	  why	  CAND1	  does	  not	  sequester	  Cul1/Rbx1	  in	  
vivo	  when	  neddylation	  is	  inhibited	  (Bennett	  et	  al.,	  2010).	  Although	  neddylation	  allows	  for	  extremely	  tight	  binding	  in	  the	  presence	  of	  CAND1,	  in	  the	  absence	  of	  neddylation	  SCF	  complexes	  still	  have	  a	  Kd	  of	  600	  nM.	  	  
	  
Figure	  3.3	  |	  Fboxes	  Remove	  CAND1.	  a,	  100	  nM	  radiolabeled	  Cul1/Rbx1	  PKA	  preincubated	  with	  300	  nM	  CAND1	  was	  mixed	  with	  pre-­‐incubated	  15	  µM	  Nedd8,	  300	  nM	  Fboxes/Skp1,	  1	  µM	  Nedd8	  E1,	  and	  10	  µM	  Ubc12.	  b,	  150	  nM	  Cul1/Rbx1	  was	  pre-­‐incubated	  with	  150	  nM	  Skp2/Skp1	  for	  5	  min	  then	  mixed	  with	  150	  nM	  Fbxw7/Skp1,	  600	  nM	  radiolabeled	  CycE	  and	  either	  buffer	  or	  200	  nM	  CAND1.	  After	  5	  min,	  15	  µM	  Nedd8,	  1	  µM	  Nedd8	  E1,	  and	  10	  µM	  Ubc12	  were	  added	  to	  the	  mix.	  After	  5	  min,	  pre-­‐incubated	  60	  µM	  Ubiquitin,	  1	  µM	  Ubiquitin	  E1,	  and	  10	  µM	  Cdc34b	  were	  added	  to	  the	  mix.	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CAND1	  functions	  as	  an	  Fbox	  exchange	  factor	  Inspection	  of	  Figure	  3.4,	  which	  summarizes	  all	  the	  rates	  measured	  here,	  suggests	  a	  manner	  in	  which	  CAND1	  can	  stimulate	  activity	  in	  a	  purified	  system.	  If	  multiple	  Fboxes	  are	  used	  in	  the	  same	  ubiquitylation	  assay,	  then	  pre-­‐incubation	  with	  saturating	  amounts	  of	  Fbox/Skp1	  relative	  to	  Cul1/Rbx1	  should	  reduce	  the	  rate	  of	  ubiquitylation	  of	  a	  second	  Fbox/Skp1.	  However,	  addition	  of	  CAND1	  should	  allow	  the	  second	  Fbox/Skp1	  complex	  access	  to	  Cul1/Rbx1.	  Neddylation	  of	  the	  complexes	  should	  then	  lock	  them	  down	  in	  respect	  to	  CAND1.	  Under	  these	  conditions,	  CAND1	  did	  in	  fact	  stimulate	  the	  ubiquitylation	  assay	  (Figure	  3.3b).	  Taken	  together,	  CAND1	  appears	  to	  function	  as	  an	  exchange	  factor	  that	  drastically	  modulates	  the	  direct	  assembly	  of	  SCF	  complexes	  in	  a	  neddylation	  dependent	  manner.	  Here	  we	  establish	  the	  first	  kinetic	  framework	  for	  the	  dynamic	  assembly	  of	  SCF	  complexes	  using	  a	  direct	  real	  time	  biophysical	  assay.	  We	  conclude	  that	  CAND1	  is	  directly	  involved	  in	  the	  assembly	  of	  SCF	  complexes	  because	  it	  serves	  as	  an	  exchange	  factor	  for	  Fbox/Skp1	  complexes.	  Our	  kinetic	  framework	  serves	  as	  a	  starting	  point	  to	  re-­‐evaluate	  the	  function	  of	  CAND1	  in	  vivo.	  Three	  ideas	  emerge	  from	  the	  synthesis	  of	  our	  kinetic	  model	  and	  genetic	  studies.	  First,	  CAND1	  may	  be	  necessary	  for	  incorporation	  of	  newly	  synthesized	  Fboxes	  if	  all	  the	  Cul1/Rbx1	  complexes	  are	  saturated.	  Second,	  CAND1	  may	  be	  needed	  to	  release	  ubiquitylated	  Fboxes	  from	  Cul1/Rbx1	  to	  ensure	  their	  proper	  degradation.	  Third,	  CAND1	  may	  function	  as	  an	  exchange	  factor	  that	  is	  specifically	  localized,	  giving	  another	  layer	  of	  control	  over	  SCF	  complex	  assembly	  in	  the	  cell.	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Figure	  3.4	  |	  Fboxes	  Remove	  CAND1.	  The	  model	  is	  derived	  from	  all	  the	  rates	  measured	  here.	  The	  transient	  complex	  is	  in	  brackets.	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Methods	  
Fluorimeter	  scans	  were	  performed	  on	  FluoroLog-­‐3	  (Jobin	  Yvon)	  in	  a	  buffer	  containing	  30	  mM	  Tris	  pH	  7.6,	  100	  mM	  NaCl,	  0.5	  mM	  DTT,	  and	  1	  mg/ml	  Ovalbumin	  (Sigma)	  in	  a	  volume	  of	  250	  μl.	  Mixtures	  were	  excited	  at	  430	  nm	  and	  the	  emissions	  were	  scanned	  from	  450	  nm	  to	  650	  nm.	  Stop	  flow	  reactions	  were	  performed	  on	  a	  Kintek	  stop	  flow	  machine	  in	  the	  same	  buffer	  as	  the	  fluorimeter	  scans.	  Ubiquitylation	  reactions	  were	  performed	  as	  described	  (Pierce	  et	  al.,	  2009).	  Proteins	  were	  purified	  as	  described	  (Pierce	  et	  al.,	  2009).	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Chapter	  4:	  
Unpublished	  Work	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   This	  chapter	  is	  included	  to	  provide	  a	  summary	  of	  the	  many	  assays	  and	  experiments	  that	  were	  not	  taken	  to	  completion.	  Most,	  but	  not	  all,	  of	  the	  experiments	  that	  have	  found	  their	  way	  into	  this	  chapter	  provide	  evidence	  for	  a	  conformational	  change	  in	  SCF	  upon	  substrate	  binding.	  Likely,	  this	  change	  is	  occurring	  in	  the	  Fbox	  protein	  and	  is	  independent	  of	  neddylation	  status.	  However,	  there	  are	  several	  contradictory	  results,	  and	  the	  function	  of	  this	  conformational	  change,	  if	  it	  does	  exist,	  remains	  a	  mystery.	  It	  is	  my	  hope	  that	  including	  this	  chapter	  here	  will	  stimulate	  further	  work	  on	  this	  topic.	  	  
	  
Substrate	  Induced	  Conformational	  Change	  	  	   The	  ubiquitylation	  rates	  for	  human	  SCF	  complexes	  show	  a	  clear	  inconsistency	  between	  the	  multi-­‐turnover	  kcat	  and	  the	  observed	  single	  turnover	  rate	  (Saha	  and	  Deshaies,	  2008).	  For	  SCFβ-­‐TrCP	  and	  Cdc34,	  the	  kcat	  is	  0.05	  min-­‐1	  and	  the	  kobs	  for	  single	  turnover	  is	  0.3	  min-­‐1.	  For	  neddylated	  SCFβ-­‐TrCP	  and	  Cdc34,	  the	  kcat	  is	  0.2	  min-­‐1	  and	  the	  kobs	  for	  single	  turnover	  is	  3	  min-­‐1.	  When	  starting	  with	  a	  mono-­‐ubiquitylated	  substrate,	  the	  kcat	  is	  2	  min-­‐1	  and	  the	  kobs	  for	  single	  turnover	  is	  >20	  min-­‐
1.	  Under	  all	  conditions	  tested,	  the	  single	  turnover	  rate	  is	  faster	  than	  the	  multi-­‐turnover,	  indicating	  that	  a	  step	  after	  the	  transfer	  of	  ubiquitin	  is	  rate-­‐limiting.	  Currently,	  the	  origin	  of	  this	  phenomenon	  remains	  unclear.	  	  	   Previously,	  a	  yeast	  single	  encounter	  ubiquitylation	  revealed	  that	  the	  rate-­‐limiting	  first	  ubiquitin	  transfer	  for	  SCFCdc4	  and	  its	  substrate	  CycE	  is	  0.2	  s-­‐1	  and	  the	  off	  rate	  of	  CycE	  and	  its	  ubiquitylated	  products	  is	  0.4	  s-­‐1	  (Pierce	  et	  al.,	  2009).	  To	  determine	  if	  the	  above	  phenomenon	  seen	  for	  human	  SCF	  complexes	  also	  occurs	  in	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yeast	  SCF	  complexes,	  I	  adapted	  the	  yeast	  ubiquitylation	  assay	  previously	  used	  for	  single	  encounter	  reactions	  to	  multi-­‐turnover	  reactions	  (Pierce	  et	  al.,	  2009).	  At	  a	  saturating	  concentration	  of	  CycE,	  the	  multi-­‐turnover	  rate	  for	  ubiquitylation	  was	  0.03	  s-­‐1	  (Figure	  4.1).	  Importantly,	  the	  positive	  intercept	  for	  the	  multi-­‐turnover	  reaction	  in	  Figure	  4.1	  indicates	  that	  a	  burst	  phase	  was	  present	  in	  this	  reaction.	  When	  I	  repeated	  the	  reaction	  on	  a	  quench	  flow	  apparatus	  for	  higher	  time	  resolution	  and	  with	  a	  lower	  concentration	  of	  substrate,	  a	  clear	  burst	  phase	  emerged	  (Figure	  4.2).	  The	  rate	  constant	  of	  the	  first	  phase	  in	  Figure	  4.2	  is	  0.24	  s-­‐1,	  in	  good	  agreement	  with	  the	  rate-­‐limiting	  first	  ubiquitin	  transfer.	  The	  second	  phase	  has	  a	  rate	  constant	  of	  0.03	  s-­‐1,	  consistent	  with	  the	  multi-­‐turnover	  rate	  constant	  seen	  with	  saturating	  substrate.	  However,	  these	  numbers	  present	  a	  conundrum.	  The	  off	  rate	  of	  product	  and	  substrate	  (0.4	  s-­‐1)	  is	  faster	  than	  the	  rate	  observed	  here	  (0.03	  s-­‐1)	  indicating	  that	  a	  step	  after	  dissociation	  and	  before	  ubiquitin	  transfer	  is	  rate-­‐limiting	  for	  the	  full	  enzymatic	  cycle.	  Yet,	  the	  association	  of	  CycE	  and	  SCFCdc4	  cannot	  be	  rate-­‐limiting	  given	  that	  we	  observe	  the	  same	  rate	  when	  we	  have	  saturating	  concentrations	  of	  CycE	  (Figure	  4.1).	  This	  indicates	  that	  a	  step	  between	  substrate	  association	  and	  ubiquitin	  transfer	  is	  rate-­‐limiting.	  How	  then	  is	  it	  possible	  to	  see	  a	  burst	  phase?	  The	  reaction	  set	  up	  used	  here	  was	  to	  pre-­‐incubate	  CycE	  with	  SCFCdc4	  before	  the	  reaction.	  Thus,	  it	  was	  possible	  for	  any	  rate-­‐limiting	  step	  after	  association	  but	  before	  transfer	  to	  be	  bypassed	  at	  the	  start	  of	  the	  reaction.	  This	  predicted	  that	  a	  lag	  phase	  should	  occur	  if	  CycE	  and	  SCFCdc4	  were	  not	  pre-­‐incubated	  at	  the	  beginning	  of	  the	  reaction.	  Indeed,	  in	  a	  single	  turnover	  reaction,	  using	  wild	  type	  ubiquitin,	  a	  lag	  phase	  that	  contains	  a	  rate	  of	  0.024	  s-­‐1	  was	  observed	  (Figure	  4.3)	  (Pierce	  et	  al.,	  2009).	  An	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accurate	  measurement	  of	  the	  association	  rate	  of	  CycE	  and	  SCFCdc4,	  however,	  has	  not	  been	  made.	  In	  order	  to	  reconcile	  all	  of	  the	  measured	  rates,	  I	  insert	  an	  extra	  step	  in	  between	  substrate	  association	  and	  ubiquitin	  transfer	  (Figure	  4.4).	  Likely,	  this	  represents	  a	  conformational	  change	  induced	  by	  the	  substrate	  in	  SCFCdc4.	  My	  sole	  attempt	  to	  measure	  this	  rate	  directly,	  was	  to	  fluorescently	  label	  the	  only	  lysine	  in	  CycE	  and	  the	  active	  site	  of	  Cdc34,	  which	  is	  the	  only	  cysteine	  in	  the	  protein.	  I	  knew	  that	  the	  lysine	  in	  CycE	  and	  the	  cysteine	  in	  Cdc34	  had	  to	  come	  close	  to	  each	  other	  for	  the	  first	  ubiquitin	  transfer.	  Thus,	  I	  hypothesized	  that	  they	  would	  FRET.	  This	  FRET	  signal	  would	  likely	  occur	  after	  the	  rate	  limiting	  conformational	  change,	  if	  it	  existed,	  given	  that	  it	  occurred	  before	  the	  ubiquitin	  transfer.	  There	  was	  a	  small	  amount	  of	  FRET	  seen	  when	  Cdc34,	  SCFCdc4,	  and	  CycE	  were	  all	  mixed	  together,	  however,	  there	  were	  also	  numerous	  anomalies	  from	  several	  control	  mixing	  experiments	  (Figure	  4.5).	  Despite	  this	  I	  attempted	  to	  measure	  rates	  directly	  in	  the	  stop	  flow.	  The	  result	  was	  a	  three	  phase	  curve	  (Figure	  4.6).	  The	  first	  phase	  was	  a	  noisy	  fast	  single	  exponential	  with	  an	  observed	  rate	  of	  1.8	  s-­‐1	  that	  likely	  represents	  CycE	  associating	  with	  SCFCdc4	  and	  a	  low	  FRET	  state	  (i.e.	  CycE	  is	  close	  enough	  to	  Cdc34	  to	  FRET	  but	  it	  is	  not	  efficient).	  Then	  comes	  a	  lag	  phase	  curve	  in	  which	  the	  two	  phases	  fit	  to	  exactly	  the	  same	  rate,	  0.017	  s-­‐1.	  This	  high	  FRET	  state	  likely	  represents	  CycE	  moving	  closer	  to	  the	  active	  site	  of	  Cdc34.	  The	  rates	  seen	  here	  are	  in	  agreement	  with	  the	  slow	  rate	  measured	  in	  all	  other	  assays.	  However,	  the	  reason	  for	  a	  lag	  phase	  with	  identical	  rates	  is	  unclear.	  Unfortunately,	  many	  of	  the	  measurements	  made	  here	  were	  not	  repeated	  nor	  assays	  optimized	  because	  I	  moved	  to	  using	  the	  human	  system	  as	  a	  direct	  result	  of	  comments	  from	  reviewers	  of	  the	  Pierce	  et	  al.,	  2009.	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   When	  I	  repeated	  multi-­‐turnover	  experiments	  with	  human	  SCFβ-­‐TrCP	  and	  SCFFbxw7	  no	  burst	  phase	  was	  seen	  and	  both	  complexes	  displayed	  rates	  of	  0.18	  min-­‐1	  (Figure	  4.7).	  This	  matches	  the	  single	  turnover	  rate	  seen	  in	  Saha	  and	  Deshaies,	  2008.	  However,	  these	  reactions	  were	  performed	  with	  Fboxes	  that	  had	  been	  purified	  with	  Skp1ΔΔ.	  When	  this	  was	  repeated	  with	  SCFFbxw7	  with	  full	  length	  Skp1	  and	  with	  Skp1ΔΔ,	  the	  reactions	  were	  the	  same	  with	  no	  burst	  phase	  evident	  (Figure	  4.8).	  Thus,	  the	  dynamics	  seen	  with	  the	  yeast	  system	  did	  not	  match	  the	  dynamics	  seen	  with	  the	  subsequent	  human	  system.	  It	  is	  unclear	  at	  this	  time	  why	  Saha	  and	  Deshaies,	  2008	  had	  a	  difference	  in	  multi-­‐turnover	  versus	  single	  turnover	  rates,	  however,	  I	  suspect	  that	  in	  the	  multi-­‐turnover	  reactions,	  substrate	  was	  not	  saturating.	  The	  reason	  for	  the	  burst	  phase	  kinetics	  seen	  in	  the	  yeast	  system	  may	  be	  explainable	  by	  the	  observation	  that	  the	  attachment	  of	  the	  Nedd8	  homologue	  Rub1	  to	  Cdc53	  does	  not	  increase	  the	  rate	  ubiquitin	  transfer	  for	  SCFCdc4	  (Pierce	  et	  al.,	  2009).	  Given	  that	  Rub1	  is	  not	  essential	  in	  this	  organism	  in	  direct	  contrast	  to	  Nedd8	  in	  all	  other	  organisms,	  the	  yeast	  system	  may	  have	  evolved	  a	  mechanism	  for	  inducing	  the	  active	  conformation	  of	  Cdc53/Rbx1	  without	  Rub1.	  	  	  	   The	  processive	  measurements	  performed	  in	  Pierce	  et	  al.,	  2009	  did	  not	  include	  SCFFbxw7.	  I	  performed	  reactions	  similar	  to	  Figure	  2.1a	  (Pierce	  et	  al.,	  2009)	  with	  both	  naked	  and	  neddylated	  Cul1	  using	  either	  Cdc34	  or	  UbcH5	  (Figure	  4.9).	  These	  reactions	  were	  fractionated	  on	  large	  gradient	  gels.	  As	  with	  SCFβ-­‐TrCP,	  the	  length	  of	  chain	  was	  quite	  long	  in	  a	  single	  encounter	  (~15	  ubiquitins)	  when	  using	  Cdc34.	  The	  speed	  of	  the	  reaction	  was	  stimulated	  and	  the	  processivity	  increased	  by	  neddylation.	  UbcH5	  reactions	  on	  the	  other	  hand,	  were	  not	  very	  processive,	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containing	  mainly	  mono-­‐ubiquitylated	  species	  in	  a	  single	  encounter.	  The	  reactions	  in	  this	  case	  were	  not	  stimulated	  much	  by	  neddylation.	  	  	   To	  investigate	  changes	  in	  the	  neddylation	  rate	  of	  human	  SCF	  complexes	  based	  on	  their	  composition,	  I	  performed	  steady	  state	  measurements	  with	  and	  without	  Fbxw7/Skp1	  and	  its	  substrate	  CycE	  (Figure	  4.10).	  The	  rates	  measured	  for	  with	  and	  without	  Fbxw7/Skp1	  was	  the	  same	  (0.7	  s-­‐1).	  However,	  there	  was	  a	  distinct	  lag	  phase	  when	  CycE	  was	  included	  in	  this	  reaction.	  The	  reason	  for	  this	  observation	  remains	  unclear.	  	   Lastly,	  the	  original	  reason	  for	  the	  developing	  the	  fluorescent	  Fboxes	  was	  to	  measure	  the	  dynamics	  of	  substrate	  binding.	  Using	  a	  CycE	  substrate	  synthesized	  with	  a	  KFAM	  derivative	  instead	  of	  a	  PKA	  site	  and	  a	  Fbxw7	  labeled	  with	  AMC	  through	  a	  sortase	  reaction,	  I	  was	  able	  to	  observe	  a	  small	  amount	  of	  FRET	  that	  could	  be	  chased	  away	  with	  unlabeled	  CycE	  (Figure	  4.11).	  The	  reaction	  was	  not	  optimized	  and	  should	  be	  noted	  that	  the	  Fbxw7	  AMC/Skp1	  did	  show	  bleaching	  that	  was	  significant	  relative	  to	  the	  signal	  change	  (Figure	  4.11a).	  However,	  the	  off	  rate	  measured	  in	  the	  stop	  flow	  using	  this	  assay	  was	  0.2	  s-­‐1,	  which	  is	  in	  excellent	  agreement	  with	  the	  quench	  flow	  assays	  done	  with	  SCFCdc4	  and	  SCFβ-­‐TrCP	  in	  Pierce	  et	  al.,	  2009	  (Figure	  4.12,	  yellow	  curve).	  The	  on-­‐rate	  measurements,	  however,	  were	  confounded	  by	  a	  significant	  bleaching	  component.	  However,	  the	  rate	  of	  the	  reaction	  clearly	  increased	  with	  increasing	  CycE	  KFAM	  acceptor.	  Importantly,	  when	  Fbxw7	  AMC/Skp1	  was	  pre-­‐incubated	  with	  non-­‐labeled	  CycE,	  this	  association	  reaction	  was	  stimulated	  (Figure	  4.12,	  compare	  the	  magenta	  line	  with	  the	  black	  line).	  This	  behavior	  was	  predicted	  by	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the	  model	  in	  Figure	  4.4,	  yet	  is	  unclear	  at	  this	  time	  why	  there	  does	  not	  exist	  biphasic	  behavior	  in	  multi-­‐turnover	  ubiquitylation	  reactions	  with	  SCFFbxw7.	  
	  
Figure	  4.1	  |	  Steady	  State	  Reaction	  of	  yeast	  SCFCdc4	  at	  Saturating	  Substrate.	  10	  µM	  radiolabeled	  CycE	  was	  pre-­‐incubated	  with	  150	  nM	  SCFCdc4	  and	  mixed	  with	  15	  µM	  K0	  ubiquitin	  pre-­‐incubated	  with	  10	  µM	  Cdc34	  and	  1	  µM	  Uba1.	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Figure	  4.2	  |	  Burst	  Phase	  of	  SCFCdc4	  Multi-­‐turnover	  Reaction.	  600	  nM	  radiolabeled	  CycE	  was	  pre-­‐incubated	  with	  150	  nM	  SCFCdc4	  and	  mixed	  with	  15	  µM	  K0	  ubiquitin	  pre-­‐incubated	  with	  10	  µM	  Cdc34	  and	  1	  µM	  Uba1.	  The	  amplitude	  of	  the	  burst	  is	  120	  nM,	  the	  faster	  first	  phase	  has	  a	  rate	  of	  0.24	  s-­‐1,	  and	  the	  slower	  linear	  phase	  has	  a	  rate	  of	  0.03	  s-­‐1.	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Figure	  4.3	  |	  A	  Lag	  Phase	  Exists	  If	  CycE	  and	  SCFCdc4	  Are	  Not	  Pre-­‐incubated.	  This	  is	  the	  raw	  data	  from	  Figure	  2.2c	  (Pierce	  et	  al.,	  2009).	  A	  clear	  lag	  phase	  can	  be	  seen.	  	  
	  
Figure	  4.4	  |	  Model	  with	  conformational	  change	  inserted.	  Inserting	  a	  step	  in	  between	  substrate	  binding	  and	  ubiquitin	  transfer	  that	  can	  occur	  during	  SCFCdc4	  and	  CycE	  pre-­‐incubation	  allows	  for	  a	  simple	  model	  that	  explains	  the	  dynamics	  seen.	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Figure	  4.5	  |	  Attempted	  FRET	  Measurements	  for	  CycE	  and	  Cdc34.	  200	  nM	  CycE	  reacted	  with	  BODIPY	  Fluorescein	  	  Succinimidyl	  Ester	  and	  40	  nM	  Cdc34	  reacted	  with	  DACM,	  N-­‐(7-­‐dimethylamino-­‐4-­‐methylcoumarin-­‐3-­‐yl)	  maleimide	  were	  mixed	  in	  several	  combinations	  with	  100	  nM	  SCFCdc4.	  	  Scans	  are	  excited	  at	  380	  nm	  with	  emission	  from	  420	  nm	  to	  600	  nm.	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Figure	  4.6	  |	  Association	  of	  CycE	  and	  Cdc34	  in	  a	  stop	  flow.	  The	  reaction	  in	  Figure	  4.5	  performed	  on	  the	  stop	  apparatus	  with	  a	  filter	  to	  follow	  only	  the	  donor	  signal.	  Three	  phases	  are	  evident.	  	  













	   55	  
Figure	  4.7	  |	  SCFβ-­‐TrCP	  and	  SCFFbxw7	  have	  no	  burst	  phase.	  600	  nM	  radiolebed	  substrate	  (either	  CycE	  or	  β-­‐cat)	  was	  pre-­‐incubated	  with	  150	  nM	  SCF	  complexes	  and	  reacted	  with	  10	  µM	  Cdc34b.	  SCFβ-­‐TrCP	  and	  SCFFbxw7	  have	  rates	  of	  0.003	  per	  second	  or	  0.18	  per	  min.	  This	  matches	  the	  single	  turnover	  rates	  Saha	  and	  Deahies,	  2009	  reported.	  	  
	  
Figure	  4.8	  |	  SCFFbxw7	  with	  Skp1	  full	  length	  or	  Skp1ΔΔ .	  Reaction	  conditions	  are	  the	  same	  as	  in	  Figure	  4.7.	  When	  fit	  to	  exponentials	  or	  the	  initial	  points	  to	  a	  linear	  line,	  full	  length	  Skp1	  in	  blue	  has	  rates	  of	  0.012	  per	  second	  and	  Skp1ΔΔ 	  in	  green	  is	  0.011	  per	  second.	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Figure	  4.9	  |	  Processivity	  of	  SCFFbxw7	  with	  Cdc34	  and	  UbcH5.	  10	  nM	  radiolabeled	  CycE	  was	  pre-­‐incubated	  with	  150	  nM	  SCFFbxw7	  that	  contained	  neddylated	  Cul1	  as	  indicated.	  Either	  10	  µM	  of	  Cdc34b	  or	  UbcH5	  were	  used.	  	  	  
	   57	  
	  
Figure	  4.10	  |	  Substrate	  and	  Fbox	  Affect	  Neddylation.	  Both	  have	  a	  rate	  of	  0.7	  per	  second,	  however,	  in	  the	  presence	  of	  substrate,	  there	  is	  a	  lag	  phase.	  25	  nM	  Nedd8	  E1,	  100	  nM	  Ubc12,	  6	  µM	  Nedd8,	  1	  µM	  radiolabeled	  Cul1	  PKA,	  500	  nM	  Fbxw7/Skp1,	  and	  8	  µM	  CycE.	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Figure	  4.11	  |	  FRET	  Between	  Fbxw7	  AMC/Skp1	  and	  CycE	  KFAM.	  a,	  Fluorimeter	  scans	  exciting	  at	  380	  nm	  and	  scanning	  from	  400	  to	  550	  nm.	  30	  nM	  Fbxw7	  AMC	  in	  blue,	  then	  mixed	  to	  see	  extent	  of	  bleaching.	  b,	  30	  nM	  Fbxw7	  AMC	  mixed	  with	  580	  nM	  CycE	  KFAM	  then	  32	  µM	  CycE	  as	  chase.	  	  	  
	  
Figure	  4.12	  |	  Binding	  of	  CycE	  and	  Fbxw7	  using	  FRET.	  30	  nM	  Fbxw7	  AMC/Skp1	  mixed	  with:	  Blue	  =	  400	  nM	  CycE	  KFAM,	  Green	  =	  800	  nM	  CycE	  KFAM,	  Red	  =	  1.6	  µM	  CycE	  KFAM,	  Magenta	  =	  3.2	  µM	  CycE	  KFAM,	  Black	  is	  130	  nM	  CycE	  pre-­‐incubated	  30	  nM	  Fbxw7	  AMC	  then	  mixed	  with	  3.2	  µM	  CycE	  KFAM.	  Yellow	  is	  starting	  with	  3.2	  µM	  CycE	  KFAM	  and	  mixing	  with	  excess	  CycE	  as	  a	  chase	  gives	  an	  off	  rate	  of	  0.2	  per	  second.	  Note	  that	  the	  machine	  was	  set	  for	  two	  phase	  time	  courses	  with	  the	  first	  phase	  from	  0	  to	  30	  seconds	  (collect	  500	  time	  points)	  and	  the	  second	  phase	  from	  30	  seconds	  to	  120	  seconds	  (collect	  500	  time	  points).	  Clearly	  this	  had	  an	  effect	  on	  the	  data,	  which	  I	  attributed	  to	  bleaching	  and	  low	  FRET	  signal.	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Supplementary Figure 1 | Attachment of Rub1 to SCFCdc4 did not change ubiquitylation kinetics of CycE. 
a, The design of CycE and β-Cat. The sequence from Lys1 through pSer23 is derived directly from human cyclin E1. 
b, SCFCdc4 was bound to beads coupled to the anti-Py antibody. Beads were mixed with puri#ed Rub1, Ula1–Uba3, 
Ubc12, and ATP. After washing, the Rub1-conjugated SCFCdc4 was released with the Py peptide and analyzed by 
SDS-PAGE followed by staining with Coomassie Blue.  Lane 1: unmodi#ed SCFCdc4, lane 2: Rub1-conjugated SCFCdc4. 
c, Reaction design: SCFCdc4 or Rub1-conjugated SCFCdc4 (150 nM) was pre-mixed with 32P labeled CycE (10 nM) 
and combined with pre-mixed ubiquitin (60 µM), Uba1 (0.8 µM), Cdc34 (10 µM), and ATP. d, Reactions were evaluated 
by SDS-PAGE followed by phosphor-imaging. 
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[SCF:S0] = 0.5 * (Kd + SCF + S0) - [ 0.25 * (Kd + SCF + S0)
2 - (SCF*S0) ]
0.5
Kd = 90 nM; [SCF
Cdc4] = 150 nM; [CycE0] = 10 nM;
[SCF:S0] = 6.15 nM or 61.5% of S0; On average 17% of S0 is modi!ed
17% / 61.5% = 27.6% of bound S0 at the beginning of the reaction goes on to get modi!ed
S1 S2 S3 S4 S5 S6 S7 S8
0.032 0.11 0.17 0.23 0.20 0.14 0.075 0.035
72.4% of bound S0 at the beginning of the reaction does not get modi!ed
c
Normalized Average Final Distribution λCycE
1 2 3 4 5 6 7 8
# of ubiquitins in chain
fraction of substrates m
odi!ed
Average






















±0.0084 ±0.026 ±0.021 ±0.010 ±0.012 ±0.014 ±0.014 ±0.0036
0.04 0.05 0.07 0.11 0.13 0.13 0.11 0.09
±0.008 ±0.008 ±0.015 ±0.015 ±0.01 ±0.007 ±0.013 ±0.008
0.07 0.04 0.02 0.01 0.010.11
±0.012 ±0.009 ±0.006 ±0.004 ±0.005±0.008
S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12 S13 S14








[SCF:S0] = 0.5 * (Kd + SCF + S0) - [ 0.25 * (Kd + SCF + S0)
2 - (SCF*S0) ]
0.5
Kd = 480 nM; [SCF
β-TrCP] = 500 nM; [β-cat0] = 100 nM;
[SCF:S0] = 48.5 nM or 48.5% of S0; On average 3.7% of S0 is modi!ed
3.7% / 48.5% = 7.6% of bound S0 at the beginning of the reaction goes on to get modi!ed
92.4% of bound S0 at the beginning of the reaction does not get modi!ed
f
g
Supplementary Figure 2 | Calculation of λ. a, For clarity, Figure 1a is reproduced here. b, The distributions of products in reaction 3 
were subtracted from the distribution of products in reaction 2 at each time point and then normalized. c, The average of the 
distributions shown in b is λCycE. d,  The fractional amounts of each product (S1 – S8) that comprise the distribution λCycE. 
e,  The fractional amounts of each product (S1 – S14) that comprise the distribution λβ-Cat. f, Calculation of the percent CycE 
bound to SCFCdc4 at the beginning of the reaction, based on the reported Kd for binding of CycE to Cdc4.
21 Combined with 
the kinetics of Fig. 1a the percent of productive encounters was calculated. g, Calculation of the percent β-Cat bound to SCFβ-TrCP 
at the beginning of the reaction, based on the reported Kd for binding of Ub-β-Cat to β-TrCP.
22 Combined with the kinetics of Fig. 1b 
the percent of productive encounters was calculated.
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Supplementary Figure 3 | An example of calculating λ from η and φ. In this example, we assigned 
distributions to η and φ. To calculate λ, we took multiple convolutions of η with itself as governed 
by φ. In our example, 25% of substrates underwent one transfer, for which the η value determines 
that 30% were a single ubiquitin while 70% were diubiquitin. Thus, we weight the distribution η 
by the fraction of a single transfer, φ(1)*η. 50% of substrates underwent two transfers. Each of these
two transfers selects from the pool of pre-assembled chains, thus we must consider the convolution 
of η with itself (ηη) and then w eight it by the fraction that receive two transfers, φ(2)*ηη. 
This process is repeated for the all indexes of φ, each time adding an additional convolution. 
These weighted distributions sum to give λ.
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After substracting the contribution of single transfers, 
the only way to end up with 2 ubiquitins on 
substrate is from two transfers of a single ubiquitin.
 The only way to end up with 1 ubiquitin on 






































































1 2 3 4 5 6
λ - φ(1)*η - φ(2)*η η
After substracting the contribution of single and 
double transfers, the only way to end up with 3 
ubiquitins on substrate is from three transfers 
of a single ubiquitin.
η(1)*η(1)*η(1)*φ(3) =
Thus,
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Supplementary Figure 4 | An example of calculating φ from λ and η. Deconvolution took advantage of the constraints existing on the 
lowest index of λ. Here we used λ and η from the example in Supplementary Figure 3. The only way of creating the species in λ that has a single 
ubiquitin attached to substrate was by the single transfer of a single ubiquitin. Thus, φ(1)*η(1) equals λ(1) and φ(1) is calculated by division. 
The contribution of φ(1) to λ was then calculated and subtracted from λ. The only way remaining to form λ(2), is by two transfers of a single 
ubiquitin. Thus φ(2) equals [λ-φ(1)*η](2)/[η(1)*η(1)]. This process is repeated until φ is revealed.
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of η(1) from λ







After substracting the contribution of single ubiquitins, 
the only way to end up with 2 ubiquitins on 
substrate is from a single transfer of a di-ubiquitin.
 The only way to end up with 1 ubiquitin on 

































[λ - φ(1)*η -φ(2)*η η - η η](2)φ(3)*η






































0.0320    0.1140    0.1700    0.2300    0.2010    0.1430    0.0750    0.0350
0.0322    0.1153    0.1719    0.2328    0.2015    0.1420    0.0727    0.0334
0.0332    0.1214    0.1805    0.2454    0.2032    0.1368    0.0619    0.0265
0.0349    0.1322    0.1959    0.2682    0.2027    0.1255    0.0409    0.0171
0.0370    0.1467    0.2161    0.2991    0.1946    0.1079    0.0098    0.0130
0.0395    0.1641    0.2400    0.3365    0.1726    0.0860   -0.0321    0.0266
0.0421    0.1839    0.2666    0.3799    0.1296    0.0657   -0.0878    0.0779
0.0448    0.2059    0.2954    0.4290    0.0575    0.0580   -0.1661    0.1998
0.0477    0.2299    0.3259    0.4839   -0.0531    0.0804   -0.2856    0.4476
0.0506    0.2557    0.3578    0.5446   -0.2129    0.1586   -0.4812    0.9139






















η(1) η(2) η(3) η(4) η(5) η(6) η(7) η(8) Sum(η)
1.0000    0.0000    0.0000    0.0000    0.0000    0.0000    0.0000    0.0000
0.9933    0.0067    0.0000    0.0000    0.0000    0.0000    0.0000    0.0000
0.9643    0.0344    0.0012    0.0000    0.0000    0.0000    0.0000    0.0000
0.9179    0.0753    0.0062    0.0005    0.0000    0.0000    0.0000    0.0000
0.8647    0.1170    0.0158    0.0021    0.0003    0.0000    0.0000    0.0000
0.8111    0.1532    0.0289    0.0055    0.0010    0.0002    0.0000    0.0000
0.7604    0.1822    0.0437    0.0105    0.0025    0.0006    0.0001    0.0000
0.7135    0.2044    0.0586    0.0168    0.0048    0.0014    0.0004    0.0001
0.6709    0.2209    0.0727    0.0239    0.0079    0.0026    0.0009    0.0003













φ as given by the muliptle weighted sums deconvolution of exponential η (above) and λ   
e-α*η(i)
Largest α without negative 
values (α=0.5)
Di%erence between the 





Supplementary Figure 5 | An example of 
calculating η from λ and φ. a, This example
 is similar to that in Supplementary Figure 4. 
Here, each time we discover another value 
of η we must remember to subtract the 
multi-weighted convolutions (as in 
Supplementary Figure 3) of the incomplete 
η from λ. b, Shown is the explicit example 
of searching a normalized exponential 
distribution of η by varying the rate 
parameter α. When the deconvolution 
was performed with rate parameter α=0.5, 
the &rst negative number appeared at φ(6). 
All larger rate parameters contain negative 
values. The error for this distribution was 
calculated as the di%erence in its sum from 1. 
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Supplementary Figure 6 | Deconvolution of φ from λCycE. a, Considering distributions of η that only contain η(1) and η(2), φ was calculated by 
deconvolution with λCycE. The distribution shown was that which deviated most from η(1)=100% whose φ did not contain values >1 or <0 and that 
when convoluted with φ, the sum fell within 0.95 and 1.05, or an error rate of ± 5%. b, Considering distributions of η that were exponentially distributed 
with rate parameter α. c, Considering distributions of η that were poisson distributed with average α. d, Considering distributions of η that were normal 
distributed varying the mean and SD. Random distributions were also considered (data not shown). 
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Supplementary Figure 7 | Deconvolution of η from λCycE. a, Considering distributions of φ that only contain φ(1) and φ (2), η was calculated by 
deconvolution with λCycE. The distribution shown was that which deviated most from φ(1)=100% whose η did not contain values >1 or <0 and that 
when convoluted with η, the sum fell within 0.95 and 1.05, or an error rate of ± 5%. b, Considering distributions of φ that were exponentially distributed 
with rate parameter α. c, Considering distributions of φ that were poisson distributed with average α. d, Considering distributions of φ that were normal 
distributed varying the mean and SD. Random distributions were also considered (data not shown). 
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Supplementary Figure 8 | Deconvolution of φ from λβ-Cat. a, Considering distributions of η that only contain η(1) and η(2), φ was calculated by 
deconvolution with λβ-Cat. The distribution shown was that which deviated most from η(1)=100% whose φ did not contain values >1 or <0 and 
that when convoluted with φ, the sum fell within 0.95 and 1.05, or an error rate of ± 5%. b, Considering distributions of η that were exponentially 
distributed with rate parameter α. c, Considering distributions of η that were poisson distributed with average α. d, Considering distributions of η 
that were normal distributed varying the mean and SD. Random distributions were also considered (data not shown).
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Supplementary Figure 9 | Deconvolution of η from λβ-Cat. a, Considering distributions of φ that only contain φ(1) and φ (2), η was calculated by 
deconvolution with λβ-Cat. The distribution shown was that which deviated most from φ(1)=100% whose η did not contain values >1 or <0 and that 
when convoluted with η, the sum fell within 0.95 and 1.05, or an error rate of ± 5%. b, Considering distributions of φ that were exponentially distributed 
with rate parameter α. c, Considering distributions of φ that were poisson distributed with average α. d, Considering distributions of φ that were normal
 distributed varying the mean and SD. Random distributions were also considered (data not shown). 
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Protein Mass (theoretical) Mass (measured) Abudance Peak 
Ubiquitin 8565 8565 1,250,158 1 
Cdc34~Ub 40,792 40,792 838,665 2 
  41,830 137,725 2 
  40,787 204,375 3 
  60,559 170,061 3 
  104,033 147,021 3 
  106,823 144,456 3 
  88,303 142,422 3 
  107,237 134,176 3 
  80,790 134,085 3 
  106,427 130,900 3 
  89,100 125,780 3 
  79,957 124,787 3 
 
Protein Mass (theoretical) Mass (measured) Abudance Peak 
Ubiquitin  8565 8564 1,448,614 1 
Ub-DTT 8701 8701 627,263 1 
Cdc34~Ub 40,792 40,789 2,267,926 2 
Cdc34~Ub 40,792 40,790 1,217,040 3 
Cdc34 32,245 32,242 145,616 3 
Cdc34~Ub 40,792 40,788 471,765 4 
Cdc34 32,245 32,243 326,504 4 
  60,570 176,801 4 
  80,775 156,325 4 
  79,940 153,394 4 
  60,129 144,097 4 
  61,003 116,335 4 
  61,460 112,311 4 
  59,775 103,833 4 





Supplementary Figure 10 | Mass spectrometry analysis of Cdc34. a, Chromatograms of mass spectrometry analysis of reaction containing Uba1, 
yeast Cdc34 and ubiquitin in the presence of ATP.  Where possible, species are identi!ed and the masses are compared with the theoretical value.  
Peak 3 contains multiple species including Uba1 and impurities. The theoretical masses for Cdc34~Ub2 (49,338), Cdc34~Ub3 (57,886), Cdc34~Ub4 
(66,433) are not observed. b, Chromatograms of mass spectrometry analysis of reaction containing Uba1, yeast Cdc34 and ubiquitin (Ub) in the 
presence of ATP and SCFCdc4.  Where possible, species are identi!ed and the masses are compared with the theoretical value.  Peak 4 contains 
multiple species including E1 and impurities. c, Analysis of peaks from a. d, Analysis of peaks from b.
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Protein Mass (theoretical) Mass (measured) Abudance Peak 
Ub-DTT  8701 8701 4,004,748 1 
Cdc34~Ub 40,792 40,790 856,005 2 
Cdc34 32,245 32,243 2,104,438 3 
 
Protein Mass (theoretical) Mass (measured) Abudance Peak 
Di-ubiquitin 17,111 17,093 1,219,060 1 
Cdc34~Ub2 49,338 49,339 358,429 2 
Cdc34 32,245 32,244 1,056,240 3 
Cdc34 32,245 32,243 342,426 4 
  114,412 141,956 4 
  113,442 131,956 4 
  55,481 113,943 4 
  115,141 112,219 4 
  55,890 111,557 4 
  56,788 106,226 4 
  112,563 87,983 4 
  37,546 87,790 4 
  44,326 81,153 4 
 Protein Mass (theoretical) Mass (measured) Abudance Peak 
  16,951 20,405 1 
  40,816 13,500 1 
  16,991 10,620 1 
  16,977 9,508 1 
  40,861 8524 1 
  17,008 6,772 1 
  41,838 6,612 1 
  40,900 6,249 1 
  36,023 6,204 1 
  78,867 6,008 1 
  109,318 20,828 2 
  109,554 20,484 2 
  98,618 19,802 2 
  66,153 18,346 2 
  61,032 18,301 2 
  88,227 17,086 2 
  37,291 15,688 2 
  52,670 15,672 2 
  64,288 15,270 2 
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Supplementary Figure 11 | Mass spectrometry analysis of Cdc34 controls. a, Chromatograms of mass spectrometry analysis of reaction containing 
E1, Cdc34 and ubiquitin (Ub) in the presence of ATP, SCF and DTT.  Where possible, species are identi!ed and the masses are compared with the 
theoretical value. b, Chromatograms of mass spectrometry analysis of reaction containing E1, Cdc34 and K48 di-ubiquitin in the presence of ATP. 
 Where possible, species are identi!ed and the masses are compared with the theoretical value.  Peak 4 contains multiple species including E1 
and impurities. c, Chromatograms of mass spectrometry analysis of SCFCdc4 in reaction bu"er. d, Analysis of peaks from a. e, Analysis of peaks 
from b. f, Analysis of peaks from c.
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Supplementary Figure 12 | Millisecond kinetics of a single encounter reaction. a, Samples from the same reaction shown in Fig. 2a were run on a 
12-24% tricine gel to optimize detection and quanti"cation of S2 and S5. The asterisk marks an unreactive contaminant of the labeled CycE. 
b, A zoomed plot of Fig. 3b up to 5 seconds. The error of each "t is shown in Supplementary Figure 14. c, A zoomed plot of Fig. 3e up to 5 seconds. 
The error of each "t is shown in Supplementary Figure 15.
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61.5
k2(1- k1+k2 )e-(k1+k2)t + 61.5 k2k1+k2 + (100-61.5)[S0] =
Analytical Closed Form Solutions






















k3+k4( () ) (1- (k3+k4)(k5+k6)e



























[SCF:S0] = 61.5% at t=0
S0:SCF S1:SCF S2:SCF



















Supplementary Figure  13 | Closed form solutions to a kinetic model of a single encounter reaction with η(1)=100%. The analytical solutions 
were calculated using the method of Laplace transforms. Each new species contributed two new rate constants to the overall scheme. 
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k2 = 0.3986 s
-1
k1 = 0.1829 s
-1 R-square = 0.9876
RMSE = 0.8744
95% CI = (0.165, 0.2009)
95% CI = (0.3504, 0.4467)
k4 = 0.3931 s
-1
k3 = 3.84 s
-1 R-square = 0.9787
RMSE = 0.1051
95% CI = (3.638, 4.043)
95% CI = (0.364, 0.4222)




















k6 = 0.3238 s
-1
k5 = 1.111 s
-1 R-square = 0.9607
RMSE = 0.3556
95% CI = (0.9352, 1.287)













k8 = 0.4218 s
-1
k7 = 0.8001 s
-1 R-square = 0.984
RMSE = 0.2736
95% CI = (0.6324, 0.9678)

















k10 = 1.876 s
-1
k9 = 1.619 s
-1 R-square = 0.9969
RMSE = 0.1204
95% CI = (0.8376, 2.913)














k12 = 91.47 s
-1
k11 = 59.67 s
-1 R-square = 0.9896
RMSE = 0.1427
95% CI = (-3841, 3960)

































Analytical Closed Form Solutions
k2 = 0.37 s
-1
k1 = 0.17 s
-1
k4 = 0.40 s
-1
k3 = 3.8 s
-1
k6 = 0.29 s
-1
k5 = 1.0 s
-1
k8 = 0.27 s
-1
k7 = 0.55 s
-1
k10 = 0.29 s
-1
k9 = 0.31 s
-1
k12 = 0.89 s
-1
k11 = 0.41 s
-1
Global Analysis Solutions
Standard Error = 0.00913
Standard Error = 0.0254
Standard Error = 0.3056
Standard Error = 0.0472
Standard Error = 0.124
Standard Error = 0.0497
Standard Error = 0.0942
Standard Error = 0.0617
Standard Error = 0.0968
Standard Error = 0.118
Standard Error = 0.783
Standard Error = 1.782
Supplementary Figure 14 | Comparison of rate constants estimated from analytical solutions and global regression for CycE. Comparison of the 
analytical and globally re!ned rate constants revealed that the global analysis helped to correct for the error accumulation in the analytical regression. 
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k2 = 0.3463 s
-1
k1 = 0.02839 s
-1 R-square = 0.9634
RMSE = 0.2822
95% CI = (0.02413, 0.03266)
95% CI = (0.2797, 0.413)
k4 =  0.1926 s
-1
k3 =  4.098 s
-1 R-square = 0.9112
RMSE = 0.0256
95% CI = (3.757, 4.44)
95% CI = (0.1628, 0.2224)





















k6 =  0.1926 s
-1
k5 =  5.849 s
-1 R-square = 0.8988
RMSE = 0.03
95% CI = (4.942, 6.755)
95% CI = (0.3149, 0.479)





k8 =  0.4682 s
-1
k7 =  4.278 s
-1 R-square = 0.9488
RMSE = 0.03099
95% CI = (3.614, 4.943)
95% CI = (0.3779, 0.5585)









k10 =  0.5024 s
-1
k9 =  2.927 s
-1 R-square = 0.9209
RMSE = 0.05625
95% CI = (2.092, 3.763)
95% CI = (0.3304, 0.6743)
}

























Analytical Closed Form Solutions
k2 = 0.363 s
-1
k1 = 0.03 s
-1
k4 = 0.171 s
-1
k3 = 3.58 s
-1
k6 = 0.265 s
-1
k5 = 4.45 s
-1
k8 = 0.315 s
-1
k7 = 3.22 s
-1
k10 = 0.275 s
-1
k9 = 2 s
-1
k12 = 0.372 s
-1
k11 = 1.63 s
-1
Global Analysis Solutions
Standard Error = 0.00261
Standard Error = 0.0313
Standard Error = 0.627
Standard Error = 0.0299
Standard Error = 1.1
Standard Error = 0.0658
Standard Error = 0.802
Standard Error = 0.0786
Standard Error = 0.481
Standard Error = 0.0661
Standard Error = 0.420
Standard Error = 0.0959
k14 = 0.395 s
-1
k13 = 1.21 s
-1 Standard Error = 0.382
Standard Error = 0.125
k16 = 0.467 s
-1
k15 = 1.01 s
-1 Standard Error = 0.571



























Supplementary Figure 15 | Comparison of rate constants estimated from analytical solutions and global regression for β-Cat. Comparison of 
the analytical and globally re"ned rate constants revealed that the global analysis helped to correct for the error accumulation in the analytical 
regression. The error for the β-Cat regressions are higher versus the CycE regression because of reduced fraction of substrate converted.
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k3+k4( () ) (1- (k3+k4)(k5+k6)e








Supplementary Figure 16 | Overshoot behavior reveals !ux through each species. Using the analytical solutions, the overshoot behavior was 
directly correlated to the amount of !ux through each species. Each curve may be dissected into the substrate that was bound to SCF or free 
at the time of quench. The sum of these two species gives the measured curve. 
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  Supplementary	  Materials	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Supplementary	  Figure	  1	  |	  a,	  600	  nM	  radiolabeled	  CycE	  was	  pre-­‐incubated	  with	  either	  150	  nM	  Cul1/Rbx1/Fbxw7/Skp1	  or	  150	  nM	  Cul1	  NTD	  CFP/Rbx1/Fbxw7	  TAMRA/Skp1	  and	  then	  mixed	  with	  10	  µM	  Cdc34b,	  1	  µM	  Ub	  E1,	  and	  60	  µM	  Ub.	  b,	  As	  in	  Fig.	  1a	  except	  with	  70	  nM	  neddylated	  Cul1	  NTD	  CFP.	  c,	  As	  in	  Fig.	  1b	  except	  with	  5	  nM	  neddylated	  Cul1	  NTD	  CFP.	  d,	  As	  in	  Fig.	  1e	  except	  with	  70	  nM	  neddylated	  Cul1	  NTD	  CFP.	  e,	  Scans	  from	  indicated	  time	  points	  in	  Fig.	  1f.	  f,	  As	  in	  Supplementary	  Fig.	  1a	  except	  with	  Fbxw7/Skp1	  or	  Fbxw7/Skp1ΔΔ.	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